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Section 1
Abstract: Trans-species Transcriptomic Comparison of in vitro and in vivo Neural Cells
RNAseq has recently evolved into a powerful tool for the analysis and comparison of
different cell types within and across organisms, and allows for accurate, reproducible
measurements of the transcriptome of these cells. Here, RNA from three different neural cells
types (oligodendrocyte progenitor cells, neurons, and astrocytes) in rats (R. norvegicus) are
grown in vitro then sequenced and aligned to the rn5 genome assembly. Furthermore, RNA from
two different human (H. sapiens) neural cell types (neurons and astrocytes) grown in vitro were
also sequenced and aligned to the hg38 assembly. An in vivo dataset of RNAseq reads was
identified from literature, containing data for all three cell types in mice. These reads were
aligned to the mm10 genome assembly, the annotation of which was then converted into its
orthologous coordinates for rnor5 and hg38. The expression of all data was then quantified in
terms of the mouse annotation, normalized, and compared to determine differences in expression.
Differential gene expression and pathway analysis across these data have identified a
number of pathways and genes which are significantly differently expressed and enriched in in
vivo cells as compared to in vitro, as well as specific differences between cell types, showing that
especially when targeting certain diseases in vitro cells should not be used as a drop-in
replacement for in vivo. Similarities and differences were also observed between this RNA-seq
data and the microarray data presented in previous in vitro/in vivo studies involving the same
cell types and species. These data are presented and discussed along with the first comprehensive
protocol for comparing RNAseq data between species.
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Section 2
Introduction: Applications of next-generation sequencing in neural cells and neurological
diseases
Neural tissue constitutes one of the most complex types of tissues in mammals, and
despite being the subject of a great deal of study over the years, is still somewhat poorly
understood. The brain consists of many different cell types with varied unique roles, all of which
are crucial for proper brain function. By studying these discrete cell types and how they relate to
one another, a better understanding of how the brain functions as a system can be elucidated.
This in turn can then be directly applied to facilitate a better understanding of various
neurological diseases, aiding in both diagnosis and treatment.
Recently, with the advent of next-generation sequencing, it has been possible to perform
whole exome sequencing on a per-cell basis [Tang et al., 2010], allowing high-fidelity
examination of biological tissues, and enabling the quantification of the differences between
different tissue types, whether between different types of healthy tissue, or comparing healthy
tissue to diseased tissue. Over time, as the size of these datasets build up, comprehensive
transcriptomic profiles can be built of different types of cells against which new data can be
compared. These can be used to diagnose diseases, assess success and effects of various drugs or
genetic modifications, and allow for personalized treatment of cancers and disorders targeted
against the expression of the affected individual.
One particular region of interest in these studies is the brain, which is among the most
important organs in the human body. It has been the subject of a great deal of research, due to its
importance relating to human intelligence, in which it plays a star role. It is also the root of a
number of unpleasant diseases, including Huntington's Disease and Alzheimer's Disease, and
volumes of research have been published on the causes and effects of these and other diseases.
The brain is also one of the more difficult organs to study, especially in humans, due to the
difficulty and risk involved in taking comprehensive biopsies from living specimens. For these
and other reasons, the brain continues to be a hot area of research in the treatment of cancers and
other diseases as well as for possible targets for positive genetic engineering.
A) Biological significance of neural tissue
The brain is made up of a large number of different cell types, with discrete functions
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which are all vital to the proper function of the central and peripheral nervous systems. Foremost
among these is the neuron, the primary vehicle for long-distance electrical communication and
computation among cells in mammals. Neurons are interconnected cells which carry electrical
signals from all over the mammalian body to the central nervous system (CNS) and back, and
which process that information within the CNS to determine which signals are appropriate to
send next. They are arguably the most important cell type in the body, enabling the computations
required for important behaviors such as balance, communication, and the ability to learn and
make decisions. Neurons send signals amongst themselves by means of changing electrical
potentials using a chemical gradient across the cell membrane, which can proliferate along the
axon of the cell to the synapse at the end, where neurotransmitters are released in accordance
with the nature of the electrical signal, stimulating the receiving neuron to modulate its own
electrical potential accordingly.
The genes expressed in a neuron are extremely important for its proper functioning,
modulating the production, transport, release, and uptake of neurotransmitters among many other
tasks. Changes in gene expression of neurons can lead to over- or under-expression of important
proteins, changing their levels in and around the cell, which can radically change the overall
topology of the nervous system and lead to severe disorders. For example, Parkinson's Disease is
characterized by accumulation in certain cells of alpha-synuclein and a subsequent deficiency of
dopamine in the brain as the cells producing it die, and Huntington's Disease is caused by the
production and accumulation of mutant Htt protein.
Neurons, capable as they are, cannot function properly without an extensive support
network of non-neuronal cells which provide a variety of auxiliary functions including physical
support, homeostatic regulation, and providing nutrients. Glial cells such as astrocytes and
oligodendrocytes fill this niche, performing essential roles without which the mammalian
nervous system would collapse. Astrocytes are star-shaped cells, with a number of important
functions within the central nervous system. They provide a physical support network to the
neurons, giving them a structure to hold them in place and facilitate their growth of connections.
They hold important stores of glycogen, providing the surrounding cells with glucose as needed.
They interact with the synapses of neurons, and work to both produce and remove
neurotransmitters and other necessary compounds from the intercellular areas. Oligodendrocyte
progenitor cells are precursor cells which are involved in the production of oligodendrocytes,
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which are the cells partially responsible for the production and maintenance of myelin in the
central nervous system.
B) The uses of next-generation sequencing
Next-generation sequencing (NGS) to quantify, analyze, and compare biological tissue
has become an invaluable tool for biological scientists in recent years, allowing for accurate,
reproducible measurements of transcriptomics. While other methods of quantifying the exome of
a particular cell or tissue, such as microarrays have been around for many years, they frequently
have many limitations. Microarrays can have cross-hybridization artifacts, detection difficulties
due to the dye, and can be very limited in terms of alternative splicing [Mortazavi et al., 2008].
These constraints make it difficult to comprehensively find and analyze all RNA molecules
which may be relevant to a given experiment, and comparison between experiments can be
problematic due to the analog nature of the data signals [Schena et al., 1995]. New sequencing
technologies have the capacity to deliver sequencing results for trillions of base pairs in under
three days, from a single machine [Illumina Spec. Hiseq X Ten, 2015]. These sequencers can be
used together with other techniques to comprehensively sequence all of the RNA present within a
cell after the generation of cDNA, allowing for the accurate counting of the numbers of
molecules present in the cell. Depending on the preparation of the sample, RNA-seq samples can
be prepared for generalized cell types, for specific tissue regions, or even for individual cells
[Tang et al., 2010].
The general process for RNAseq is as follows. First, the cells with the desired conditions
are prepared and isolated. The RNA is isolated from these cell(s) using one of the available
published techniques, and is treated to remove any contaminating genomic DNA that may have
been present, as well as to remove as much rRNA as possible. Ribosomal RNA is by far the most
common RNA present in the cell, but generally from the view of the RNAseq experiment, is
some of the least interesting. As the purpose of most RNAseq analyses is to examine differences
in expression between treatment types, mRNA is generally the target for the sequencing, and
sometimes other RNAs such as siRNA. The removal of rRNA will reduce the amount of noise in
the final product, as well as reducing the amount of sequencing necessary to yield the desired
level of mRNA counts. The RNA content levels can be optimized in this way through either the
removal of the rRNA, or the selective enrichment of the mRNA [Wilhelm et al., 2010]. The
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isolated RNA is then reverse transcribed to form cDNA, which can be fragmented and sequenced
on a high-throughput sequencer.
The sequencer will return a data file, often in FASTQ format, which describes all of the
reads, or individual nucleic acid molecules, which were sequenced. The base pair sequence for
each read is reported, as well as a quality score at each position and some other metadata. Many
sequencers will perform their own rudimentary quality control, indicating in the output file
whether or not a read meets a quality threshold or should be discarded. A bioinformaticist may
wish to run further quality control on the output as well- if, for example, numerous samples were
run at once, the molecules may have been barcoded, and the output may need to be
demultiplexed and the barcodes trimmed. Tools such as FastQC may be useful in assessing
quality. Once the researcher is satisfied with the quality of their raw data, the reads are aligned to
a reference genome. A number of sources for reference genomes exist- one excellent example is
the University of California, Santa Cruz (UCSC), which has published reference genomes and
annotations for dozens of species. A short read aligner such as SHRiMP, Bowtie/Tophat, GSNAP,
or others are used to do this. The different aligners have various features which make them more
or less appropriate for different sorts of analyses, and the researcher may choose different tools
based on which they deem most appropriate. Differences between the aligners include statistical
models for alignment, treatment of potential splicing sites, and handling of ties for alignment
locations. Alignment software may also have features allowing for further quality control.
The aligned reads are generally output in Sequence Alignment/Map (SAM) format [Li et
al., 2009], which is a somewhat human-readable format showing the location, base pair
sequence, and alignment quality of the input reads. They are often then converted into BAM
format, which is a compressed binary version of the SAM data. BAM files can also be sorted and
indexed for significant performance gains. Following alignment, reads are matched up against an
annotation to quantify which gene each read belongs to, and then provide either raw counts, or
normalized counts in the form of FPKM or similar, which may be used for comparisons of the
data to other treatments.
Unlike microarrays which use linear models to assess differential expression of genes
between samples [Smyth et al., 2004], most popular differential expression analysis software for
RNAseq uses a negative binomial dispersion to estimate distributions of reads, a technique that is
also used with serial analysis of gene expression (SAGE) experiments [Robinson et al., 2008].
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Poisson distributions have also been used in some cases. These distributions are used to generate
lists of differentially expressed genes between the samples in question, which can then be tested
for enriched categories/pathways from the Gene Ontology, KEGG, or other sources which take
the list of genes and allows a more broad biological insight into the differences between the
samples being tested [Oshlack et al., 2010]. For both RNAseq and microarray experiments, large
numbers of tools have been published which will perform this gene enrichment [Nam et al.,
2008]. Several of those tools which are geared towards RNAseq will be discussed in the
Methods.
D) Application of NGS to medical science
The ability to quantitatively compare the transcriptomes of two different groups is
immensely valuable and has far-reaching implications for biological understanding and the
treatment of disease. By comparing a diseased cell or tissue to a healthy sample of the same, the
exact effects of the disease can be quantified and shown compared to what is healthy, and
analysis of these differences may even yield the root cause of the disease. The differences
between cells may be shown by isolating samples of healthy tissue and comparing expression
profiles of different cell types. When testing a new drug, or other treatment for some disease,
treated cells or tissues may be compared against controls to examine any possible undesirable
side-effects. Furthermore, when examining a disease of some sort, diseases which may outwardly
appear to have identical symptoms can turn out to have in fact very different transcriptome
profiles, and respond very differently to certain treatments. In this way, and others, the
applications of RNAseq and other next-generation technologies combined with the quickly
falling costs of sequencing large amounts of nucleic acid hold enormous promise for the
personalization of medicine and the customizability of treatments for many conditions.
Other applications involve the assessment of the probable accuracy of certain treatments
or research paths that may be less suitable than previously thought. For example, research is
commonly done on in vitro cells, because the logistics and expense of maintaining and
controlling a source of in vivo cells may be too much for many places. However, cells which are
grown in vitro may express certain genes or pathways differently than the same cell taken
directly from the organism in question, and if these cells are then treated with a drug intended to
treat some sort of condition, then the response to that drug may well differ depending on whether
they were raised in vitro or in vivo. If two cells were compared in vitro against in vivo, and
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pathways involved in particular diseases were found to be significantly different between the
two, then it might well be that a treatment for that condition, especially one involving that
particular part of the pathway, should be tested on in vivo cells rather than in vitro despite an
additional cost, as the in vitro conditions do not mimic those within the organism closely enough
to extrapolate results to a complete organism from a petri dish.
E) Prior work
A large body of research has been published regarding transciptomics in neural tissue in
humans, rats, and mice, although a study of the exact sort as this has not previously been done. A
selection of published works which were particularly helpful or relevant to this experiment have
been summarized below, sorted by publication date.
Paper

Summary of relevance

Dugas et al., 2006

Compared OPCs and oligodendrocytes in rats using microarrays.
Included a comparison of in vivo OPCs to in vitro OPCs, reporting
similarity of expression especially in myelin-related genes

Lovatt et al., 2007

Compared astrocytes and neurons in vivo in mice using microarrays

Cahoy et al., 2008

Published a comprehensive transcriptome analysis of astrocytes,
neurons, and oligodendrocytes in vivo in mice using microarrays.
Also performed a comparison of in vitro astrocytes to in vivo,
reporting on the Notch pathway and top enriched genes.

Miller et al., 2010

Meta-analysis examining differences in expression in astrocytes,
neurons, and OPCs between mice and humans based on microarray
data from other studies. Focused specifically on Alzheimer's related
genes and pathways. Used similarity of gene networks to determine
which genes to compare betwene species.

Rowitch et al., 2010

Reported on the developmental genetics of a number of different
stages and types of neural stem cells, especially with regard to glia
and OPCs.

Liu et al., 2011

Compared RNAseq and microarray data between humans,
chimpanzees, and rhesus monkeys based on pairwise genome
alignments. This paper formed the basis of the cross-species
protocol used.

Zhang et al., 2014

Generated an RNAseq database for astrocytes, neurons, and OPCs
in vivo in mice, among other cell types as well, to create a database
of splicing in these transcriptomes. It is this study which provided
the mouse RNAseq data used to be compared against the in vitro
data.
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Section 3
Methods: A computational pipeline for RNA-seq pathway analysis between similar cells in
different species.
Description and Uses of the protocol
This protocol addresses a number of common needs in the processing of RNA-seq data,
including alignment to a genome, quantification of gene expression based on an annotation,
lifting of annotations between species to their best orthologues, differential expression analysis
between multiple species and between multiple samples of one species, and pathway enrichment
and analysis of differentially expressed genes. While many different protocols already exist for
the alignment of reads to a genome, the quantification of expression, and differential expression
analysis, the vast majority of these protocols only deal with the comparison of samples within a
single species, and cannot be used with multiple annotations. Quantifications of differences in
expression between species have a number of important applications to the field. Non-human
mammal models are used for many medical treatment tests, and differences in pathways or
annotation completeness can cause important information to be overlooked. Furthermore, metaanalyses of several studies where similar treatments have been applied to a variety of species, a
comparison between species based upon one particular reference is an excellent way to evaluate
the frequency of various reactions to the treatment.
RNA-seq analysis typically begins with the sequencing of many individual cDNA reads,
which are usually no more than several hundred base pairs long. The sequencer assesses the
quality the sequencing of each base pair in each read, and returns the read and its quality along
with some other metadata in a file. The scientist then examines this file, and may assess the
overall quality of the data and use other tools to improve the average quality. Other operations
are often performed in this step as well, such as the demultiplexing of barcoded samples which
were sequenced together. At the end of the quality control process, the file with the high-quality
reads is then the starting point for this protocol.
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Differential
Expression data
Pathview

Differentially expressed
KEGG pathway charts
Figure 3-1: A flowchart showing the general analysis pathway from start to finish
The reads are then aligned to the genome of the organism whence they came using
SHRiMP [Rumble et al., 2009]. This part of the protocol is dependent upon input data, and is not
significantly distinct from many other methods of sequencing- it can easily be exchanged for
another alignment platform of the user's preference (Tophat [Trapnell et al., 2009], GSNAP [Wu
et al., 2010], or others). The output of many sequencing programs is in the Sequence
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Alignment/Map (SAM) format [Li et al., 2009], and is then converted to a binary format for
improved performance and space efficiency. Performance is further improved by sorting and
indexing the file
The next step is then to quantify gene expression based on a gene annotation. This part of
the protocol is quite specific to comparisons between species, and is sensitive to errors. A single
reference species is identified, in this protocol the mm10 annotation [Harrow et al., 2006][Meyer
et al., 2013], and the annotation file is downloaded in gff format. Constitutive exons- that is,
exons which are always included in the final gene product- are then identified in this annotation
using MISO, and all parts of the annotation which are not constitutive exons are discarded.
Pairwise genome alignments of the chosen reference annotation to each query species are
downloaded in turn in AXT format[Chiaromonte et al., 2002] [Kent et al., 2003] [Schwartz et al.,
2003]. All exons in the reference annotation which have complete orthologous regions in all
query species genomes are then lifted to their respective orthologous position in each query
species, while maintaining the gene IDs of the reference species. The resulting annotations are
then converted from GFF format to GTF format using the gffread utility from the Cufflinks
package [Trapnell et al., 2010]. This step is discussed in more detail in the next section as it is
not covered in any other published protocols.
The annotations are then used to count the number of reads from the indexed alignment
file which align to each exon, which is then used to calculate expression on a per-gene level. For
comparison between species this pipeline uses a count-based method, rather than an FPKMbased method for quantifying expression, as it is easier to integrate this into downstream
expression analysis tools. The reason for this is threefold- firstly, many tools which compute
differential expression (e.g. Cuffdiff) require that one annotation be given for all input alignment
files, which will not function when comparing between species, with a different annotation for
each species. Secondly, FPKM measurements take into account and report on the expression of
genomic locations which are not included in the annotation, and these measurements will affect
the values reported by the genes within the alignment. While this is desirable in most analysis
cases, when comparing between species it makes less sense- as isoform discovery when
comparing between species in this method is essentially impossible, and indeed the annotations
are pared down to only those constitutive exons orthologously present in all queried species,
differential expression analysis should focus on those exons and genes which can be measured in
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all samples. Finally, while single-sample FPKM programs such as Cufflinks can quantify
alignments an annotation, since FPKM values are adjusted for feature length, it would become
extremely difficult to adjust these values across species accounting for possible differences in
feature length. Counts, on the other hand, are not adjusted by feature length- this means that
counts cannot be used to compare expression of two different genes within a sample, such as
when performing isoform-based analyses, but they are much more able to be used to compare
expression of individual genes across multiple samples and species. Cufflinks, Cuffdiff, and
other related tools may also be used as normal to compare expression within species using the
data produced by the mapping portion of this protocol.
Once count data has been generated for each sample against its respective annotation
using Rsubread [Liao et al., 2013], which returns the count information in a list. This list can
then be read into edgeR [Robinson et al., 2009] which is able to perform a number of statistical
tests upon the count data. Of primary importance, differential expression is computed for each
gene between each sample, using a negative binomial distribution [McCarthy et al., 2012]. The
list of differentially expressed genes may then be subset by magnitude and reported directly, as
well as lend itself to further downstream analysis. In particular, this method will cover the use of
SPIA [Tarca et al., 2008], GAGE [Luo et al., 2009] and Pathview [Luo et al., 2013], which are
analysis packages from Bioconductor [Gentleman et al., 2004]. GAGE, which stands for
“Generally Applicable Gene-set Enrichment”, will examine all differential expression between
two samples, and determine which annotated cellular pathways are significantly different
between the two samples, based on a given set of pathway annotations. This protocol utilizes
pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) [Kanehisa et al., 2000],
although others are supported by the software as well. This is done using a standard gene set
enrichment, where DEGs are ranked by log fold change, and then based on ranks and numbers of
pathways, certain pathways are determined to be significant. SPIA performs similarly, but has the
added feature of also assessing the topology of the pathway- for example, if one side of a
comparison has many more genes involved in activation of a particular pathway and the other
side has many more involved in repression, it will rate that pathway as more significant and
interesting than were the DEGs randomly distributed through the pathway. However, this can
also backfire if genes which are involved in both activation and repression are both upregulated
in one sample, possibly reducing the likelihood of discovering pathways- for this reason, both
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GAGE and SPIA are used. Once significantly different pathways have been determined,
Pathview is given the gene names, pathway names, and expression levels, and it will query the
KEGG servers for the pathway diagrams, annotating and coloring them in accordance with
expression. Pathway-level expression analysis is the final goal of this protocol, enabling the
researcher to view and explore the differences between two samples of different species, in terms
of one reference species' pathways, tying the difference in gene expression into the true
biological differences, allowing for a much more human-readable set of results.
In addition to the above-mentioned pathway analysis charts, a number of scripts were
written which leverage various other R packages to display various interesting aspects of the data
using heatmaps, Venn diagrams, and other charts.
Generation of cross-species genome annotations
The key to being able to compare RNAseq data between different species is the
generation of a cross-species genome annotation. To do this, one species is selected as a
'reference' species against which any other query species will be compared. In this protocol, the
mouse genome and annotation are selected as the reference, because the mouse constitutes the in
vivo RNAseq data, while rat and human are in vitro- as the differences between in vitro and in
vivo cells are of primary interest here, to minimize variation in the comparison which may be
introduced by the new annotation. The goal is to ultimately compare all data from all relevant
samples to one another in terms of genes and pathways in the reference species. The best way to
do this is using orthologous genome regions- since many annotations may be variably complete,
or have similarly named genes which have different functions, comparisons at a base pair level
are used to determine which regions in the query species' genomes are to match up to each region
in the reference annotation.
One tool which is commonly used for the translation of genomic coordinates from one
annotation version to another, or indeed one species to another, is the University of California
Santa Cruz (UCSC)'s liftOver utility. However, the chain/net files used by liftOver are ill suited
to comparisons between species, as small changes to the parameters can cause huge changes in
the output when there is a large evolutionary distance between the two species. To adjust for this,
the UCSC conservation track, which is the best alignment between two genomes, is used instead.
This adds significant robustness to the comparison- not only are the comparison tracks partially
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based on orthology as well as simple alignment score, but they are also symmetrical- that is, if a
region in the mouse genome is converted to the rat genome using the conservation track, the
resulting region in rat will convert back to the original region in the mouse. This is not always
the case when using liftOver, due to the asymmetrical nature of dynamic masking in Blastz. The
symmetry of the conservation track allows for a much more robust comparison between species.
Furthermore, the reference annotation is filtered such that only constitutive exons are
included- that is, all exons which are always incorporated into the final gene product. As exact
alternative splicings are far less likely to be conserved between species than entire genes, and
because the additional small regions compared between genomes, conservation the cross-species
annotations may have 'exons' for a gene on entirely separate chromosomes- as such, finding
isoforms when comparing between species would be essentially meaningless, and is omitted
from this protocol altogether.
Alternatives and Comparisons with Other Methods
To the best of the knowledge of the author, this is the first published protocol which
provides a generally-applicable set of instructions for the comparison of RNA-seq data between
different species. Previous papers have been published which have compared RNA-seq data
between closely related species [Liu et al., 2011], and it is upon their methods sections that the
novel parts of this protocol is partially based, while adapting many other parts of this protocol on
subsets of previously published protocols [Anders et al., 2013] and software which are already
commonly used throughout the field. Another paper [Kristiansson et al., 2013] defines and
implements a method for cross-species gene expression analysis as well, though this method
does not provide a detailed step-by-step protocol for upstream preparation and downstream
analyses. While the general idea is the same as the Liu paper- comparison of expression based on
orthology- the implementation is very different. There was a paper comparing human and mouse
transcriptome data as well [Miller et al., 2010] which used similarity of gene networks to
generate a consensus network that was used to compare expression between the species. For time
and complexity reasons, the Liu paper was selected as the basis for the cross-species analysis
method. The goal of this protocol was to use off-the-shelf software when possible for the
analysis of the data, while writing and publishing new code for ease of comparisons between
species. There are often many options available for most steps in the protocol, which will work
with similar input and output files, the user may alter some steps to use one of the many other
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tools available, if they prefer to use Tophat rather than SHRiMP, or DEseq instead of edgeR, as
drop-in replacements. The Kristiansson method for cross-species comparison, while a viable
alternative to the Liu method, is not a drop-in replacement and a separate protocol would need be
constructed to analyze data with it properly.
Confounding Effects
As this protocol seeks to compare RNA-seq data between different species using one
annotation, differences in the procurement and treatment of the cells can introduce variations into
the data, as well as the relatedness of the species. The quantification of orthologous genes across
species can at best only be an approximation based on alignment scores, and in distantly related
species this may introduce confounding of the data. Furthermore, if the protocol is used to
compare data from more than one study, differences in cell or data treatment between the studies
may also introduce variation. It is advised that the user keeps track of all software versions and
cell treatment protocols used, so that any differences may be used to determine whether
downstream differences are the result of these factors or true biological expression differences.
In the particular data shown, it is very difficult to differentiate differences in cells resulting from
rat/mouse species divergence, and from in vitro/in vivo setting differences.
Materials
Hardware
The computing resources necessary for this protocol are heavy, particularly for the
alignment of sequencing reads to the reference genome. While there are ways to reduce the
memory footprint of the alignment if absolutely necessary, it is recommended to use a computer
with at least 8 cores and 60GB of RAM, as well as at least 500GB of hard drive space.
Additional resources will allow multiple samples to be run simultaneously, significantly speeding
the analysis.
Software
This protocol was constructed on and for a GNU/Linux operating system, and commands
are given assuming that the user is using a POSIX-compliant operating system with access to a
shell such as bash. While it is possible to run the protocol under Microsoft Windows, several
additional steps would be necessary for the proper execution of various programs, which is
outside the scope of this protocol. The author recommends one of the Debian or Red Hat distros
for this protocol.
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The SHRiMP alignment software may be downloaded from
http://compbio.cs.toronto.edu/shrimp/.
To work with the alignment files, SAMtools will be necessary for conversion, sorting,
and indexing of the files. It may be installed from your distro's software repository or
downloaded from http://samtools.sourceforge.net/.
Determination of constitutive exons leverages MISO, which can be downloaded from
https://miso.readthedocs.org/en/fastmiso/index.html.
Various scripts and utilities for working with axt files, as well as various downstream
analyses, where written by the author and may be downloaded from a git repo created for this
protocol at https://github.com/ploverso.
The gffread utility, as well as other programs for downstream analysis, are part of the
Cufflinks package and may be installed from your distro's software repository or downloaded
from https://cole-trapnell-lab.github.io/cufflinks/.
The R statistical computing environment may be downloaded from
http://cran.rstudio.com/.
Bioconductor and several of its packages (Rsubread, edgeR, gage, gageData, pathview,
and Org.mm.eg.db) as well as all dependencies may be installed using the Bioconductor package
installer.
The gplots R package may be installed using R's built-in package installer.
Following is the output of R's sessionInfo() command, which will show the versions of
all packages used:
> sessionInfo()
R version 3.1.1 (2014-07-10)
Platform: x86_64-pc-linux-gnu (64-bit)
locale:
[1] LC_CTYPE=en_US.utf8
[3] LC_TIME=en_US.utf8
[5] LC_MONETARY=en_US.utf8
[7] LC_PAPER=en_US.utf8
[9] LC_ADDRESS=C
[11] LC_MEASUREMENT=en_US.utf8
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LC_NUMERIC=C
LC_COLLATE=en_US.utf8
LC_MESSAGES=en_US.utf8
LC_NAME=C
LC_TELEPHONE=C
LC_IDENTIFICATION=C

attached base packages:
[1] grid
splines
grDevices
[8] utils
datasets

stats4

methods

base

other attached packages:
[1] org.Rn.eg.db_3.0.0
BiocInstaller_1.16.4
[4] VennDiagram_1.6.9
[7] gageData_2.3.1
[10] org.Hs.eg.db_3.0.0
[13] XML_3.98-1.1
[16] org.Mm.eg.db_3.0.0
[19] AnnotationDbi_1.28.2
[22] S4Vectors_0.4.0
BiocGenerics_0.12.1
[25] biomaRt_2.22.0

parallel

stats

graphics

Rsubread_1.16.1
RColorBrewer_1.1-2
gage_2.16.0
KEGGgraph_1.24.0
edgeR_3.8.6
RSQLite_1.0.0
GenomeInfoDb_1.2.4
Biobase_2.26.0

loaded via a namespace (and not attached):
[1] Biostrings_2.34.1 bitops_1.0-6
gdata_2.13.3
[5] gtools_3.4.2
httr_0.6.1
KernSmooth_2.23-14
[9] png_0.1-7
RCurl_1.95-4.5
stringr_0.6.2
[13] tools_3.1.1
XVector_0.6.0

gplots_2.16.0
pathview_1.6.0
graph_1.44.1
limma_3.22.7
DBI_0.3.1
IRanges_2.0.1

caTools_1.17.1
KEGGREST_1.6.4
Rgraphviz_2.10.0
zlibbioc_1.12.0

Input Data
RNAseq data from three different species were used: Rattus norvegicus, Mus musculus,
and Homo sapiens. The samples for rat and human were prepared as described below, and then
sent to the University of Rochester Genomics Research Center (URGRC), who performed the
sequencing and quality control on the reads. The cleaned sequencing reads were made available
by and downloaded from URGRC to Research Computing at the Rochester Institute of
Technology (RC) in FASTQ format. These data consist of two samples each of astrocytes,
neurons, and oligodendrocyte progenitor cells (OPCs) from rats, all in vitro, and two samples of
astrocytes and one sample of neurons from humans, also in vitro. The mouse samples were
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prepared and sequenced as described in Zhang et al., 2014, and the input FASTQ files for in vivo
astrocytes, neurons, and OPCs were downloaded from
https://www.ebi.ac.uk/ena/data/view/SRP033200 to RC and extracted. All input files were based
on output from Illumina sequencing machines- while other sequencers are supported by the
alignment software, any conversions necessary are outside of the scope of this protocol.
Preparation of cells
Cells mentioned above were grown with 85% Dulbecco’s Modified Eagle’s Medium
(DMEM) and 15% Fetal Bovine Serum (FBS). The cells were grown in 37°C incubator with 5%
CO2 and a humidified atmosphere. Old medium was aspirated off and replaced with new fresh
pre-warmed media daily. The cells were subcultured on days 4 and 7. When sub culturing the
cells the media was removed and the cells were washed with Dulbeccos Phosphate-Buffered
Saline (DPBS) without calcium and magnesium. The cells were then incubated with Stem Pro
Accutase Cell Dissociation Reagent for twenty minutes while rocking the flasks back and forth
every five minutes. The media that was removed initially was added back to the flask and the
cells were moved to a pre-rinsed 15mL centrifuge tube and spun at 250 x g for five minutes. On
day 10, RNA was isolated and sent to URGRC for sequencing.
Protocol
1. Preparation of reference genome
The reference genomes for human, rat, and mouse (hg38, rnor5, and mm10 respectively)
were downloaded in compressed FASTA format from various sources- the rnor5 and mm10
genomes with annotations were downloaded from Illumina's igenomes FTP server:
ftp://igenome:G3nom3s4u@ussd-ftp.illumina.com/ while the hg38 genome FASTA was
downloaded from the Sanger Institute, using version 20:
ftp://ftp.sanger.ac.uk/pub/gencode/Gencode_human/release_20/GRCh38.genome.fa.gz.
Furthermore, the comprehensive gene annotation for mm10 was downloaded in GFF format
from GENCODE: http://www.gencodegenes.org/mouse_releases/3.html. Once the genome
FASTA file was downloaded and extracted for each species, it was pre-processed with SHRiMP,
which will greatly decrease the time required to align the RNAseq samples to that genome. The
general command used to pre-process the genomes, run from the location of each genome.fa file,
is:
$ ~/SHRiMP_2_2_3/bin/gmapper-ls -S <assemblyName> -N 8 genome.fa
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This will index the genome and save the indexes and projections of the genome to file, which are
then loaded for each sample to align against. If this pre-processing step is not done, then it will
be performed prior to mapping for each sample, causing the alignment step per sample to
take many hours longer. The index files will be several times larger than the original genome.fa
files, and should be placed in a location convenient to the RNAseq samples.
2. Alignment of RNAseq reads to indexed genome
Each sample should then be aligned to its respective genome, specified with the assembly
name given when indexing. This step is the most computationally intensive, and should be
performed on a computer with at least 60GB of RAM. This step can be parallelized easily, and
allotting more CPU cores to the alignment will allow it to run significantly faster. The author
suggests writing a simple bash script to run the alignments, to reduce the amount of oversight
necessary for large numbers of samples. The general command used to align the rat and human
data is:
$ ~/SHRiMP_2_2_3/bin/gmapper-ls -Q --qv-offset 33 -L
./<indexLocation>/<assemblyName> -N 8 --all-contigs $infile >
$outfile
This will output the alignment to the specified output file in SAM format. This command is only
valid for the rat and human data, which is single-ended RNAseq data. The mouse data is pairedend data, with each sample name suffixed with a _1 or _2 in the FASTQ filename. The command
used for the mouse data was, generally:
$ ~/SHRiMP_2_2_3/bin/gmapper-ls -Q --qv-offset 33 -L
./<indexLocation>/mm10 -N 8 --all-contigs -p opp-in -1 $infile1
-2 $infile2 > $outfile
The -p option specifies how SHRiMP will attempt to align the paired-end data. Mapping
statistics for all samples is shown in Table 1.
3. Conversion, sorting, and indexing of SAM files
The SAM output of SHRiMP is a plain-text file. While somewhat human-readable, it is
uncompressed and each SAM file may be many tens of GB. The filesize will slow access to the
file when it is accessed for analysis, and inflate space required on a hard drive. To solve these
problems, the SAM files are converted to the compressed binary BAM format, then sorted and
indexed. The general commands used for this are as follows:
$ samtools view -bS $inSAM > $tempBAM
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$ samtools sort $tempBAM $outPrefix && rm $tempBAM
$ samtools index $outBAM
BAM files which are sorted and indexed have greatly enhanced access speeds, which will speed
up downstream analysis. Additionally, BAM files tend to be only a small fraction the size of the
SAM files whence they came, freeing up disk space and reducing RAM requirements for
downstream analysis programs which load the entire BAM file into memory.
Alternative protocol entry point
If the user decided to use a different alignment method than SHRiMP, such as Tophat or
GSNAP, then they should enter the protocol at this point with their sorted, indexed BAM files.
4. Generation of cross-species annotations
Starting with the GFF file downloaded from GENCODE in a previous step, the
constitutive exons must be identified. This is done with the exon_utils program, part of MISO.
The command:
$ exon_utils --get-const-exons mm10.gff --min-exon-size 100
--output-dir exons/
This will extract all constitutive exons (that is, all exons always incorporated into the
final gene product) which are greater than 100bp into a GFF file in a specified folder. This file is
then broken down into individual chromosomes using a perl script from the github repo specified
above, gffToChrs.pl.
$ perl gffToChrs.pl mm10.const_exons.gff ./gffChrs/
Next, the axt files must be downloaded, one axt file per chromosome. The wget utility
may be helpful in doing so. The axt files are provided for many species by UCSC, for example:
http://hgdownload.cse.ucsc.edu/goldenPath/mm10/vsRn5/axtNet/. Then, the axtLift.pl script is
used to convert each chromosome of the reference annotation to the coordinates of the query
annotation. Exons which do not match 100% are discarded- that is, if the exon hangs off one end
or the other of the aligned region. Alignments with gaps are supported. However, before this can
be run, the annotation must be filtered. Downstream analysis programs will not work if the gene
names in the annotations differ between species. So, prior to translating the mm10 genomic
coordinates to rnor5 or hg38, the entire mm10 annotation is first run against each genome
conservation track, and the mm10 annotation lines are output as-is into a new single annotation
file for each species, which can then be combined. A perl script has been written for this purpose.
To run, for example:
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$ perl axtCompare.pl ./gffChrs/chr1.gff
./mm10TOrn5/chr1.mm10.rn5.net.axt ./rn5.gff
$ perl axtCompare.pl ./gffChrs/chr1.gff
./mm10TOhg38/chr1.mm10.hg38.net.axt ./hg38.gff
Note that the above command is an example, and must be run for each chromosome for
each species. The script only supports a single input GFF and AXT file at a time, so a bash script
may be useful to run all chromosomes for the reference species. If this step needs to be redone
for any reason, the output files should be deleted or renamed prior to beginning a new run, as the
script will append rather than overwriting files.
The purpose of the above script is to enable the comparison of the exons which map to
rnor5 and hg38, and subset the final annotations for all three species- mm10, hg38, and rnor5into only the genes which perfectly remap to both hg38 and rnor5. It tests only that the exon will
remap correctly, but does not actually change the annotation line. Combining the files and
finding the lines in common can be done trivially with R. Using the files mentioned above:
$ R
> rnData <- read.delim("rn5.gff", header=F)
> hgData <- read.delim("hg38.gff", header=F)
> finalData <- merge(rnData, hgData)
> write.table(finalData, file="mm10_final.gff", row.names=F,
col.names=F, quote=F, sep="\t")
Once this has been done, this new GFF file must again be split into chromosomes, similar
to above:
$ perl gffToChrs.pl mm10_final.gff ./finalChrs/
Then, the individual chromosome files are mapped to the new genomes. The axtLift.pl
script will do this. To run this script, for example:
$ perl axtLift.pl ./finalChrs/chr1.gff
./mm10TOrn5/chr1.mm10.rn5.net.axt ./rn5/
$ perl axtLift.pl ./finalChrs/chr1.gff
./mm10TOhg38/chr1.mm10.hg38.net.axt ./hg38/
It should be noted that the output folder must be created prior to running the script.
Furthermore, any files in the folders should be deleted if this step needs to be rerun, as the script
will append rather than overwriting files. The script only supports a single input GFF and AXT
file, so a bash script may be useful to run all chromosomes for the reference species. It is not
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recommended to run the chromosomes in parallel, as each input chromosome may map to any of
the output chromosome files.
Once this completes, the GFF files should be sorted and combined into a single
annotation file. This is again easy to do with R. For example with hg38:
$ R
> final <- data.frame(matrix(nrow=0, ncol=9))
> for(gffFl in dir("hg38")){
+ gffData <- read.table(paste0("./hg38/", gffFl), header=F,
sep="\t", as.is=T)
+ gffData <- gffData[order(gffData[,4]),]
+ final <- rbind(final, gffData)
+ }
> write.table(final, file="hg38_final.gff", row.names=F,
col.names=F, quote=F, sep="\t")
Important: The final annotation for each species MUST be in the same chromosomal
order as the genome.fa file for that species, otherwise the final GFF file will be sorted improperly
and many gene quantification tools will fail to work. Additionally, chromosomes must be in the
same format as in genome.fa for that species (e.g. “chr10” vs “10”).
Finally, the GFF files should be converted to GTF format. GTF is essentially a simplified,
more specific form of the GFF format. The Cufflinks package comes with a utility for
performing this conversion, gffread.
$ gffread hg38_final.gff -T -o hg38.gtf
$ gffread mm10_final.gff -T -o mm10.gtf
$ gffread rn5_final.gff -T -o rnor5.gtf
These GTF files are then used together with the BAM files generated previous to quantify
expression at a per-gene level.
5. Counting of gene features
The next step is to quantify the expression for each sample, which here is done using the
Bioconductor package Rsubread. The package will take the BAM files and the GTF annotation,
as well as some other parameters describing the data, and produce a count table of each gene ID.
As the count data is returned as a variable to the R environment rather than written to a file, and
as Rsubread will output information such as the number and percent of successfully counted
reads, it may be advisable to use a script for counting and to redirect terminal output to a file for
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saving. The R commands used for the counting of all data in this experiment, as well as for
saving the R environment with all count data for later analysis, are as follows:
$ R
> library(Rsubread)
> allSpecies <- c("rnor5", "hg38", "mm10")
> origDir <- getwd()
> countedData <- list()
> for(species in allSpecies){
+ cells <- c("ast1", "ast2", "neu1", "neu2", "opc1", "opc2")
+ setwd(species)
+ annotLoc <- paste0("../annotations/", species, ".gtf")
+ if(species == "hg38"){
+ cells <- c("ast1", "ast2", "neu1")
+ }
+ for(cell in cells){
+ cellData <- paste0(cell, ".bam")
+ isPair <- F
+ if(species == "mm10"){
+ isPair <- T
+ }
+ thisID <- paste0(species, cell)
+ sampleCount <- featureCounts(cellData, annot.ext=annotLoc,
isGTFAnnotationFile=T, GTF.featureType="exon",
GTF.attrType="gene_id", useMetaFeatures=TRUE,
allowMultiOverlap=FALSE, isPairedEnd=isPair, nthreads=4L)
+ countedData[[thisID]] <- sampleCount
+ }
+ setwd(origDir)
+ }
> save(countedData, file="counts.Rdata")
This last command will save all of the data, from all of the samples, to a file which can be
re-loaded by R at any time. This is useful when analysis may be done on a computer that the
researcher may not have access to all the time, or when further analysis may be desired at a later
time. Unless saved, the data is deleted when the R environment is closed.
The data is then prepared for loading into edgeR. The input format for edgeR is a matrix
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with the counts for each sample for each gene ID- it may simplify analyses to extract these to
their own text file using R:
> load("counts.Rdata")
> counts <-countedData[[1]][[1]]
> counts <- data.frame(counts[order(rownames(counts)),])
> for(samp in names(countedData)[2:length(names(countedData))]){
+ newData <- countedData[[samp]][[1]]
+ newData <- data.frame(newData[rownames(newData) %in%
rownames(counts),])
+ rows <- rownames(counts)[rownames(counts) %in%
rownames(newData)]
+ counts <- data.frame(counts[rownames(counts) %in%
rownames(newData),])
+ rownames(counts) <- rows
+ newData <- newData[order(names(newData))]
+ counts <- cbind(counts, newData)
+ }
> colnames(counts) <- names(countedData)
> write.table(counts, file="counts.txt", quote=F, sep="\t")
The above commands do some additional sorting and filtering to ensure that all genes for
all samples are in the correct order, and there are no gene IDs which do not exist for all samples.
6. Differential expression analysis
Once the files with the counts have been prepared, they can be analyzed with edgeR for
differential expression. EdgeR was chosen in particular for the differential expression analysis
thanks to several useful features. Firstly, it supports input in the form of a single matrix of counts
with gene IDs as the names for each row, allowing easy integration of the counted data from the
previous step. Secondly, it has superb support for complex comparisons and experimental
design- it is trivial to compare individual samples, or specify groups for comparison, or even to
make two comparisons, and compare the results of that comparison against one another, allowing
for essentially any dimension of analysis desired.
To load the count data into edgeR and then build the labeled experiment design, estimate
the count dispersions, and build a fitted model, the following commands were used which are
defined in an R script in the github repo mentioned above. Full code for the downstream analysis
25

can be found in the appendices- due to the length of the code, complete commands have been
omitted from the main document, and while all steps will be explained, only some particular
commands will be shown.
The generated experimental design matrix(specifying which samples/replicates in the
'counts.txt' file to include under which labels) appears as follows:
> design
hgast hgneu mmast mmneu mmopc rnast rnneu rnopc
1
0
0
0
0
0
1
0
0
2
0
0
0
0
0
1
0
0
3
0
0
0
0
0
0
1
0
4
0
0
0
0
0
0
1
0
5
0
0
0
0
0
0
0
1
6
0
0
0
0
0
0
0
1
7
0
0
0
0
1
0
0
0
8
0
0
0
0
1
0
0
0
9
0
0
0
1
0
0
0
0
10
0
0
0
1
0
0
0
0
11
0
0
1
0
0
0
0
0
12
0
0
1
0
0
0
0
0
13
1
0
0
0
0
0
0
0
14
1
0
0
0
0
0
0
0
15
0
1
0
0
0
0
0
0
attr(,"assign")
[1] 1 1 1 1 1 1 1 1
attr(,"contrasts")
attr(,"contrasts")$Group
[1] "contr.treatment
While not strictly necessary, a design matrix is exceptionally useful as it then allows
comparisons to be built with the makeContrasts() function in edgeR, specifying groups to
compare by their group name, rather than manually entering number values representing which
columns to include at certain weights. The following command was used to define 48
comparisons which would be made among the data, each of which would have its own
differential gene expression analysis.
my.contrasts <- makeContrasts(
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rn.astVSrest = rnast - (rnneu + rnopc)/2,
rn.neuVSrest = rnneu - (rnast + rnopc)/2,
rn.opcVSrest = rnopc - (rnneu + rnast)/2,
mm.astVSrest = mmast - (mmneu + mmopc)/2,
mm.neuVSrest = mmneu - (mmast + mmopc)/2,
mm.opcVSrest = mmopc - (mmneu + mmast)/2,
ast.vtVSvv = (hgast + rnast)/2 - mmast,
neu.vtVSvv = (hgneu + rnneu)/2 - mmneu,
opc.vtVSvv = rnopc - mmopc,
all.vtVSvv = (hgast + hgneu + rnast + rnneu + rnopc)/5 (mmast + mmneu + mmopc)/3,
all.rnVSmm = (rnast + rnneu + rnopc)/3 - (mmast + mmneu +
mmopc)/3,
ast.rnVShg = rnast - hgast,
ast.rnVSmm = rnast - mmast,
ast.hgVSmm = hgast - mmast,
neu.rnVShg = rnneu - hgneu,
neu.rnVSmm = rnneu - mmneu,
neu.hgVSmm = hgneu - mmneu,
rn.astVSneu = rnast - rnneu,
mm.astVSneu = mmast - mmneu,
hg.astVSneu = hgast - hgneu,
rn.astVSopc = rnast - rnopc,
mm.astVSopc = mmast - mmopc,
rn.neuVSopc = rnneu - rnopc,
mm.neuVSopc = mmneu - mmopc,
vt.astVSneu = (rnast + hgast)/2 - (rnneu + hgneu)/2,
vv.astVSneu = mmast - mmneu,
vt.astVSopc = (rnast + hgast)/2 - rnopc,
vv.astVSopc = mmast - mmopc,
vt.neuVSopc = (rnneu + hgneu)/2 - rnopc,
vv.neuVSopc = mmneu - mmopc,
astneu.vtVSvv = ((rnast - rnneu) + (hgast - hgneu))/2 (mmast - mmneu),
astopc.vtVSvv = ((rnast + hgast)/2 - rnopc) - (mmast mmopc),
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neuopc.vtVSvv = ((rnneu + hgneu)/2 - rnopc) - (mmneu mmopc),
astRest.vtVSvv = ((rnast + hgast)/2 - (rnneu + hgneu +
rnopc)/3) - (mmast - (mmneu + mmopc)/2),
neuRest.vtVSvv = ((rnneu + hgneu)/2 - (rnast + hgast +
rnopc)/3) - (mmneu - (mmast + mmopc)/2),
opcRest.vtVSvv = (rnopc - (rnneu + hgneu + rnast + hgast)/4)
- (mmopc - (mmneu + mmast)/2),
astneu.rnVSvv = (rnast - rnneu) - (mmast - mmneu),
astopc.rnVSvv = (rnast - rnopc) - (mmast - mmopc),
neuopc.rnVSvv = (rnneu - rnopc) - (mmneu - mmopc),
astRest.rnVSvv = (rnast - (rnneu + rnopc)/2) - (mmast (mmneu + mmopc)/2),
neuRest.rnVSvv = (rnneu - (rnast + rnopc)/2) - (mmneu (mmast + mmopc)/2),
opcRest.rnVSvv = (rnopc - (rnneu + rnast)/2) - (mmopc (mmneu + mmast)/2),
vt.astVSrest = (rnast + hgast)/2 - (rnneu + hgneu +
rnopc)/3,
vt.neuVSrest = (rnneu + hgneu)/2 - (rnast + hgast +
rnopc)/3,
vt.opcVSrest = rnopc - (rnneu + hgneu + rnast + hgast)/4,
all.astVSneu = (rnast + mmast + hgast)/3 - (rnneu + mmneu +
hgneu)/3,
all.astVSrest = (rnast + mmast + hgast)/3 - (rnneu + mmneu
+ hgneu + rnopc + mmopc)/5,
all.neuVSrest = (rnneu + mmneu + hgneu)/3 - (rnast + mmast
+ hgast + rnopc + mmopc)/5,
all.opcVSrest = (rnopc + mmopc)/2 - (rnneu + mmneu + hgneu
+ rnast + mmast + hgast)/6,
levels=design)
The above comparisons allow for the determination of differentially expressed genes
between in vitro and in vivo cells, both generally across all cell types as well as on a per-cell-type
basis. Comparisons of cellular differences between the individual species as well as comparisons
between the cell types are also defined. Not all of the above comparisons wound up having their
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data used for the final reporting of results- however, the presence of many of these comparisons
allowed for additional error checking of the data, and additionally, as analyses were done, certain
comparisons which had not been of interest before came to be of interest- it can be useful to have
all of the data pre-processed and ready to go if it should be decided that any subset of it may be
needed, rather than adding onto already existing data structures after the fact.
The next step is to use glmLRT() and the fitted model to find all differentially expressed
genes, which is done by looping through the data frame of comparisons. The result of each
comparison is saved in a list for later access.
The table of fold changes and FDR-corrected p-values is then used with GAGE and SPIA
to perform KEGG pathway enrichment for that comparison. Note: GAGE and SPIA will perform
its enrichment analysis on only the fold change values, and cannot easily be made to account for
the sample sizes for that comparison in edgeR. This causes the q-value outputs from GAGE to be
falsely inflated. To account for this, the edgeR differential expression table is filtered to only
include genes with a p-value of <0.05, and a FDR of <0.01. Only these significantly expressed
genes with a low FDR are used in the calculation of enriched pathways. All KEGG pathway IDs
found with a p-value <0.05 are then returned and also saved to a list for further use.
7. Visualization of data
Using the gene expression and pathway data contained in the lists described above, the
data is then graphed and visualized. Firstly, Pathview was used to visualize differentially
enriched pathways, downloading the pathway map from KEGG, and then color-coding each gene
with the fold-change differences. The pathways enriched in individual cell types when
comparing in vitro to in vivo were combined, and the expression data for all three cell types was
visualized on single graphs per pathway, splitting the coloring of each gene into thirds. Pathways
showing the difference between astrocytes and neurons were similarly combined, splitting each
gene marker into thirds by species. The pathways differentially expressed in general between in
vitro/in vivo were visualized on their own set of pathways. The R code for these comparisons is
included in the github repo mentioned above.
The general gene expression profiles were then visualized using R scripts written for the
purpose. The gene expression values for each gene were quantified from the gene read counts
with log2(counts per million(CPM) + 1). Several charts were then generated from this. Firstly, a
heatmap showing the 200 genes with the highest expression in any sample were shown, sorted by
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similarity of expression across all samples. The log2(CPM + 1) table was then regenerated, using
mean counts per species cell type, as divided in the experimental design above. A heatmap was
drawn with the top 200 expressed genes of any cell type, sorted by similarity of expression
across all cell types. Finally, a heatmap was drawn with the top 25 expressed genes for each of
the eight cell types in turn, sorted top to bottom by expression level in that cell type. These
heatmaps illustrate the similarities and differences among the cell types examined, allowing for
easy visual identification of potential problems in the data that may not have been clear earlier in
the protocol, such as if two replicates of the same cell type present extremely different
expression profiles. These heatmaps were drawn using the “gplots” R package. In the heatmaps,
the gene symbol names are displayed next to each row. The cross-species annotation uses
exclusively Ensembl gene IDs- the biomaRt Bioconductor package was used to translate these
IDs to gene symbols.
Furthermore, Venn diagrams were generated using the “VennDiagram” R package to
visualize which genes among lists of DEGs are in common or different between various
comparisons, which has the potential to grant further biological insight. Tables of the numbers of
DEGs were also produced.
8. Pathway analysis and visualization
While lists of differentially expressed genes are a detailed and robust way to represent
differences in expression between two samples, they are not a very friendly format for humans to
understand. A table of thousands of gene ID tags, each with individual expression values, is not
easily read and visually extrapolated to biological significance. To this end, GAGE and SPIA are
used to analyze the previously generated gene lists and determine the differentially expressed
pathways. Unfortunately, neither of these software packages has the capacity to properly deal
with asymmetrical input samples in the way that this experiment requires- for this reason, the
FDR values reported by either of these software packages will not be accurate. To deal with this,
the FDR values for individual genes as provided by edgeR are used instead, and the pathway
output of SPIA and GAGE are instead filtered by p-value instead of q-value. When these
pathways are passed into Pathview for visualization, only the genes with a q-value less than 0.05
are provided, so in the final pathway charts only significant genes are used. It should be noted
that the SPIA package provided by Bioconductor has many of its significance values hardcoded,
and also lacks handling for some data aberrations such as NA values in R. The source code for
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this package was downloaded and modified to suit the purposes of this experiment. As SPIA is
licensed under the GPL, this modified source code must be made available to the general public.
It has been hosted in the github repo mentioned above. Scripts were written which would
perform both GAGE and SPIA pathway enrichments on all of the comparisons mentioned above,
and save the results. As both of these packages take Entrez IDs as input, and the genes are listed
by Ensembl ID, a script was written to leverage Bioconductor's “org.Mm.eg.db” package to
convert the IDs.
Once lists of significantly enriched pathways have been generated, the KEGG IDs of
enriched pathways for each comparison is fed into Pathview, which will query each pathway ID
against the KEGG database and download the PNG and XML files for that pathway map. It will
also take the list of DEGs and log fold change values for that comparison, and color-code genes
on the pathway map to illustrate which parts of that pathway are differently expressed, and in
what direction. These images are then saved to a folder for manual examination. Furthermore, as
each list of differentially expressed pathways is produced, tables of all pathway names and
significance values are saved for future reporting.
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Section 4
Results: Comparison of transcriptional profiling between in vivo and in vitro settings in
mammalian neural cells
Overview of results
The results presented herein are separated into several sections. Firstly, statistics and
percentages collected during the alignment and quantification of RNA-seq samples are presented
in tabular form. SHRiMP reports in detail on mapping statistics for each sample, which can be
important to look over before proceeding with analysis- low percentages of aligned reads, or
samples with large outliers from the other samples, may indicate a problem with the quality
control of the data. Counts and percentages are then shown for the quantification of the aligned
samples against each of the two annotations used for each species.
The next section shows the gene quantification and pathway analysis results of
comparisons between cell types within species for all in vitro samples using the literature
annotation for that species. Heatmaps of differentially expressed genes (DEGs) are presented for
each comparison, and then selected pathway maps are shown with DEGs colored, to illustrate
differences in cellular activity between cell types. These pathways and DEGs are compared with
the literature to demonstrate that expected results have been attained, and verify the ability of the
experiment to provide consistent results. Then, the same comparisons are made using the crossspecies annotation generated for each species, and the results of these are then compared. By
showing that the analysis using the cross-species annotation yields similar results to the true
annotation for each species, the utility of the cross-species annotation can be confirmed, lending
additional credence to the comparison of in vitro data against its in vivo counterparts.
Once cell-type comparisons within species in vitro have been completed, the next step is
to compare the in vitro data against published in vivo data of the same cell types. These
comparisons allow the illustration of which specific biological processes are different in vitro
compared to in vivo. Papers are often published where cells are treated and analyzed in vitro, and
results are frequently extrapolated to include in vivo cells without the use of those in vivo cells
for various reasons. The results shown here identify areas of certain pathways which are
significantly different between in vitro and in vivo cells, and may provide a guideline for future
experiments as to whether in vivo cells should be sought for use, if genes or pathways shown to
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be differently expressed in that are important in the context of the experiment being undertaken.
A) Data processing: Genome alignment
The RNAseq reads for the rat, human, and mouse samples were aligned to the rnor5,
hg38, and mm10 genome assemblies respectively using SHRiMP. The output was saved in SAM
files for each sample, and then converted to BAM format to be sorted and indexed. The mapping
statistics for all input files is shown in Table 1. Very low mapping statistics for a sample can
indicate a problem with the input data, or with the commands used to align it. The mapping
statistics shown here are fairly consistent, with all samples mapping greater than 75% of their
reads, and all mapping more than 70% at a quality greater than ten.
A:
R. norvegicus

Astrocyte

Neuron replicate 1 Neuron replicate 2 OPC replicate 1

OPC

replicate 1
Reads matched

replicate 2

37,499,371

70,917,604

44,661,252

18,373,876

33,709,300

(92.2925%)

(90.7163%)

(92.6240%)

(89.9179%)

(87.7766%
)

...with QV >= 10

31,977,341

64,870,497

39,651,012

16,197,222

28,766,309

(78.7018%)

(82.9810%)

(82.2332%)

(79.2658%)

(74.9054%
)

Reads dropped

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Total matches

102,616,135

144,690,005

112,161,735

44,632,937

96,670,217

Avg hits/ Matched read 2.74

2.04

2.51

2.43

2.87

Duplicate hits pruned

4,518,414

4,189,579

1,566,548

3,948,009

3,862,843

B:
H. sapiens

Astrocyte replicate 1

Astrocyte replicate 2

Neuron replicate 2

Reads matched

42,671,125

43,979,971

37,383,296

(91.2301%)

(90.3046%)

(78.6239%)
...with QV >= 10

38,721,254

(82.7854%)

39,925,948

(81.9804%)

32,386,717
(68.1152%)

Reads dropped

0 (0%)

0 (0%)

0 (0%)

Total matches

124,458,271

127,679,763

144,344,276

Avg hits/ Matched read

2.92

2.9

3.86

Duplicate hits pruned

3,867,809

3,939,406

5,795,400

C:
M. musculus
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Astrocyte

Astrocyte

Neuron

Neuron

OPC

OPC

replicate 1

replicate 2

replicate 1

replicate 2

replicate 1

replicate 2

24,482,027

27,236,030

32,405,280

26,691,409

26,763,308

26,637,899

(82.6456%)

(85.0626%)

(85.5175%)

(78.6388%)

(83.0340%)

(81.9936%)

23,584,181

26,210,006

30,734,414

25,195,971

24,776,706

24,777,771

(79.6147%)

(81.8581%)

(81.1081%)

(74.2329%)

(76.8705%)

(76.2680%)

542,030

355,132

724,441

2,380,366

549,008

632,688

(1.8298%)

(1.1091%)

(1.9118%)

(7.0131%)

(1.7033%)

(1.9475%)

Total paired matches

42,835,593

47,459,160

70,617,958

55,945,227

55,564,357

69,030,232

Avg hits/ Pair Matched

1.75

1.74

2.18

2.10

2.08

2.59

Duplicate Paired

3,041,374

3,509,155

5,597,592

3,962,805

4,003,436

4,983,493

Additional Reads

12,659,160

12,592,596

19,994,811

15,774,322

15,850,311

20,709,809

Matched Unpaired

(21.3672%)

(19.6644%)

(26.3832%)

(23.2373%)

(24.5880%)

(31.8732%)

...with QV >= 10

3,893,594

3,670,766

3,998,582

3,783,291

3,911,560

4,155,722

(6.5719%)

(5.7322%)

(5.2761%)

(5.5732%)

(6.0679%)

(6.3958%)

Total Unpaired Matches 79,200,816

85,797,139

141,283,381

108,106,066

106,012,971

141,510,462

Avg Matches/

6.26

6.81

7.07

6.85

6.69

6.83

2,619,023

3,078,362

5,559,007

4,016,369

3,938,977

4,852,651

Pairs matched
...with QV >= 10
Pairs Dropped

Matches Pruned

Unpaired Matched Read
Duplicate Unpaired
Matches Pruned

Table 4-1: SHRiMP alignment statistics of each input file. Statistics are shown for (A) R.
norvegicus cells, single-end data from in vitro cells; (B) H. sapiens cells, single-end data from in
vitro cells, and (C) M. musculus cells, paired-end data from in vivo cells.
B) Data processing: Generation of cross-species annotations
The GFF file downloaded from GENCODE contained the current annotation of the
mm10 genome assembly. The first step towards generating cross-species alignments is the
identification of constitutive exons. Using the exon_utils program, a total of 79275 constitutive
exons was identified in the original annotation out of a pool of 651,678 known exons, 12.16% of
its original size. When the AXT files were used to find orthologous regions, it was found that
68109 (85.91%) exons mapped perfectly to the rnor5 assembly, and 59556 (75.13%) mapped
perfectly to the hg38 assembly. Taking the union of the two sets of mapped genes yielded a set of
56710 (71.54%) constitutive exons which mapped perfectly to both other species, and it is these
which formed the final assembly annotations for all three species.
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Once annotations had been generated for all three assemblies, Rsubread was used to
count the number of aligned reads which matched up to features in the annotation. The counts of
matching reads are shown in Table 2. The percentages of reads which align properly with the
annotations is quite low- but this is to be expected, as the original annotation was pared down to
a small fraction of its original size. To double-check the quality of the data, the BAM files were
also counted against the unaltered literature annotations for each species, and the percentage of
counts aligned to features using the true annotation is shown in Table 3.

R. norvegicus

Astrocyte

Astrocyte

Neuron

Neuron

OPC replicate

OPC replicate

replicate 1

replicate 2

replicate 1

replicate 2

1

2

Total reads

75497691

102616135

144690005

112161735

44632937

96670217

Successfully

11481267

13525196

20170805

15920999

5968080

12086305

(13.2%)

(13.9%)

(14.2%)

(13.4%)

(12.5%)

assigned reads (15.2%)

H. sapiens

Astrocyte replicate 1

Astrocyte replicate 2

Neuron replicate 1

Total reads

124458271

127679763

144344276

Successfully assigned reads

11207432 (9.0%)

11483640 (9.0%)

13918960 (9.6%)

M. musculus

Astrocyte

Astrocyte

Neuron

Neuron

replicate 1

replicate 2

replicate 1

replicate 2

Total fragments

79200816

85797139

141283381

108106066

106012971

141510462

Successfully

11988435

12779470

18058574

17431605

18217286

20874926

(14.9%)

(12.8%)

(16.1%)

(17.2%)

(14.8%)

assigned fragments (15.1%)

OPC replicate 1 OPC replicate 2

Table 4-2: The number of input fragments which were successfully matched against the
generated cross-species annotations are shown here. The low percentages are to be expected, as
the annotation was cut down to just over 12% of its original size.

R. norvegicus: Astrocyte

Astrocyte

Neuron

Neuron

OPC replicate

OPC replicate

rnor5

replicate 1

replicate 2

replicate 1

replicate 2

1

2

Total reads

193401932

102616135

144690005

112161735

44632937

96670217

Successfully

102861667

50267809

75601751

55520161

22265917

45077708

(49.0%)

(52.3%)

(49.5%)

(49.9%)

(46.6%)

assigned reads (53.2%)

H. sapiens:hg38
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Astrocyte replicate 1

Astrocyte replicate 2

Neuron replicate 1

Total reads

124458271

127679763

144344276

Successfully assigned reads

84417123 (67.8%)

86422474 (67.7%)

98457922 (68.2%)

M. musculus: mm10

Astrocyte

Astrocyte

Neuron

Neuron

OPC replicate OPC replicate

replicate 1

replicate 2

replicate 1

replicate 2

1

2

79200816

85797139

141283381

108106066

106012971

141510462

Successfully assigned 39834149

42129607

54378124

50623908

50289978

56724880

fragments

(49.1%)

(38.5%)

(46.8%)

(47.4%)

(40.1%)

Total fragments

(50.3%)

Table 4-3: The number of input fragments which were successfully matched against the
published annotation for that genome assembly are shown here.
The data shown prove to be quite consistent. Almost all of the SHRiMP alignments report
75-80% of reads matched with a quality value greater than or equal to ten, with the lowest still at
68%. The percentage of these reads which then properly map to the cross-species annotation is
fairly low- between 9 and 16% for most samples. However, the percentages for the rat and
mouse samples are quite close, indicating that the quality of the annotation is not significantly
worse after it has been translated across species. The percentages for the human data are lower,
but this is to be expected as humans are evolutionarily much farther from mice than rats are.
When using the corrected annotations, percentages of reads which align to known features
increases significantly, and are fairly consistent within species as well. This again indicates that
the data collected are fairly consistent and not the result of poor quality control.
C) In vitro/ in vitro comparison: Differences in expression between in vitro rat neural cells
Once features were counted, expression was quantified among the samples involved.
These were visualized first by creating a heatmap of the 200 top expressed genes in the
experiment, grouped both by sample and by overall group, shown in figure 4-1. Furthermore,
several classic cell-type-specific marker genes were selected, and a heatmap showing the
differences in expression of these genes in different cell types was generated, shown in figure 42. The marker genes shown are based on a previously published list including these genes as well
as others for other cell types [Zhang et al., 2014][Lovatt et al., 2007]. As can be seen, the marker
genes provide excellent stratification of expression by cell type, which verifies the identity of
these cells against known expression patterns. These expression patterns help indicate that there
was no contamination between the samples and that they at least generally tend to follow the
same gene expression as previously published results.
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Next, comparisons were made between the different cell types in R. norvegicus, using the
literature genome annotation by grouping the individual samples by cell type. Differences were
quantified both between individual cell types, and between each cell type and all others
combined. Figure 4-3 shows the numbers of differentially expressed genes (DEGs) in common
between the pairwise comparisons made, and figure 4-4 shows those DEGs in common between
the comparisons made of each cell against all other cell types. The data presented in both figures
is as expected. In figure 4-3, and genes highly expressed or lowly expressed in astrocytes against
the other cell types would be expected to be in common between the Ast/OPC and Ast/Neu
groups, and the same is true for the expression of OPCs in the Ast/OPC and Neu/OPC groups.
Any DEGs shared between Ast/Neu and Neu/OPC are genes where expression is significantly
increased in astrocytes as well as decreased in OPCs, or vice versa. For this reason there should
be no genes shared by Neu/OPC and Ast/Neu which are not also in Ast/OPC, and this is indeed
the case.
In figure 4-4, there should be a minimum of genes shared between any of the groups, as
for genes to be significantly increased in expression in two groups, it means the third must have
such decreased expression as to show as significant even when combined with the third cell type.
This also means that necessarily, all genes marked as upregulated in two cell types must
necessarily also be marked as downregulated in the third cell type. Examinations of the lists of
genes making up the figure has shown this to indeed be the case (data not shown).
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A

B)

Figure 4-1: The 200 genes with the highest expression in the experiment, grouped by similarity
of expression across rows. Expression by cell type (A) and by individual sample (B) is shown.
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Figure 4-2: A heatmap comparing the expression of various cell-type marker genes. The colors
indicate the z-score of the average counts per million of each gene in each cell type.
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A)

B)

Figure 4-3: DEGs which are in common between pairwise cell type comparisons. (A) shows
genes which are upregulated in the first cell type listed, while (B) shows genes which are
downregulated in the first cell type listed.
A)

B)

Figure 4-4: DEGs which are in common among comparisons of each cell type against all other
cell types. (A) shows genes which are upregulated against other cell types, while (B) shows
genes which are downregulated against other cell types.
For each of the six comparisons mentioned above, heatmaps were generated showing the
20 most significant DEGs in each direction across all involved samples, and these were then
grouped within the heatmap by similarity of expression across rows. The heatmaps are shown in
Figure 4-5.
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A)

B)

C)

D)

E)

F)

Figure 4-5: These are heatmaps showing the expression of the 20 most significant DEGs in each
direction for each pairwise comparison made. Rows are grouped based on similarity across
columns. Data is shown for each individual sample involved in that pairwise comparison.

D) In vitro/ in vitro comparison: Pathway analysis of differences between in vitro cell types
in rats
Pathway analyses of the comparisons pictured in figure 4-5 A through C were performed
using both GAGE and SPIA. The names, descriptions, and p-values of all significant pathways
found by GAGE and SPIA respectively are listed in tables, followed by selected colored
pathways charts generated by Pathview.
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Pathway
rno05332 Graft-versus-host disease
rno05330 Allograft rejection
rno05320 Autoimmune thyroid disease
rno04612 Antigen processing and presentation
rno04510 Focal adhesion
rno04060 Cytokine-cytokine receptor interaction
rno04512 ECM-receptor interaction
rno05416 Viral myocarditis
rno04610 Complement and coagulation cascades
rno04142 Lysosome
rno05146 Amoebiasis
rno05144 Malaria
rno03010 Ribosome
rno00982 Drug metabolism - cytochrome P450
rno04350 TGF-beta signaling pathway
rno04940 Type I diabetes mellitus
rno04514 Cell adhesion molecules (CAMs)
rno00980 Metabolism of xenobiotics by cytochrome P450
rno04145 Phagosome
rno04640 Hematopoietic cell lineage
rno05323 Rheumatoid arthritis
rno05322 Systemic lupus erythematosus
rno04974 Protein digestion and absorption
rno05200 Pathways in cancer
rno00590 Arachidonic acid metabolism
rno05150 Staphylococcus aureus infection
rno05140 Leishmaniasis
rno04670 Leukocyte transendothelial migration
rno00860 Porphyrin and chlorophyll metabolism
rno04620 Toll-like receptor signaling pathway
rno00480 Glutathione metabolism
rno04630 Jak-STAT signaling pathway
rno04144 Endocytosis
rno04520 Adherens junction
rno00531 Glycosaminoglycan degradation
rno04623 Cytosolic DNA-sensing pathway
rno00040 Pentose and glucuronate interconversions
rno04672 Intestinal immune network for IgA production
rno00983 Drug metabolism - other enzymes
rno05142 Chagas disease (American trypanosomiasis)
rno00511 Other glycan degradation
rno04141 Protein processing in endoplasmic reticulum
rno00053 Ascorbate and aldarate metabolism
rno00760 Nicotinate and nicotinamide metabolism
rno05160 Hepatitis C
rno05145 Toxoplasmosis
rno00500 Starch and sucrose metabolism
rno00830 Retinol metabolism
rno05222 Small cell lung cancer
rno04810 Regulation of actin cytoskeleton
rno04621 NOD-like receptor signaling pathway
rno04380 Osteoclast differentiation
rno05215 Prostate cancer
rno04622 RIG-I-like receptor signaling pathway
rno05143 African trypanosomiasis
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p.val
0.000000003
0.000000009
0.0000000978
0.0000001082
0.0000002088
0.0000002348
0.0000002802
0.0000004761
0.0000025050
0.0000032991
0.0000089427
0.0000105422
0.0001841802
0.0003615287
0.0004543827
0.0005023512
0.0005234022
0.0009306151
0.0012499831
0.0013147708
0.0018811788
0.0020510053
0.0020750815
0.0022276506
0.002701593
0.0028988925
0.0034605152
0.0034843081
0.003752418
0.003769809
0.0044779305
0.00448487
0.0049129947
0.0056614053
0.0060355516
0.0072793818
0.0084113703
0.0116850392
0.0128846527
0.0134255765
0.0154540452
0.0158079713
0.0175702463
0.0196546401
0.0202370331
0.0236900626
0.0245643317
0.0249910976
0.0251998534
0.0268862199
0.0270698123
0.033972731
0.0362009454
0.0386237579
0.0404023431

rno05100 Bacterial invasion of epithelial cells
rno04530 Tight junction
rno00340 Histidine metabolism
rno05220 Chronic myeloid leukemia
rno04210 Apoptosis

0.0406210472
0.0444436181
0.0458340763
0.0484257796
0.0485755445

Table 4-4: GAGE pathway enrichment results between astrocytes and neurons. This table shows
the names of all pathways significantly enriched between the two samples to a significance level
of p<0.05.
Name
Neuroactive ligand-receptor interaction
ECM-receptor interaction
Retrograde endocannabinoid signaling
Amoebiasis
Focal adhesion
Cytokine-cytokine receptor interaction
GABAergic synapse
Calcium signaling pathway
Glutamatergic synapse
Morphine addiction
Axon guidance
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
TNF signaling pathway
Cholinergic synapse
MAPK signaling pathway
Dilated cardiomyopathy
Type I diabetes mellitus
Graft-versus-host disease
Circadian entrainment
Malaria
Pertussis
PI3K-Akt signaling pathway
Allograft rejection
Salivary secretion
Basal cell carcinoma
Serotonergic synapse
Insulin secretion
Complement and coagulation cascades
Proteoglycans in cancer
Rap1 signaling pathway
Autoimmune thyroid disease
Chagas disease (American trypanosomiasis)
cAMP signaling pathway
Inflammatory bowel disease (IBD)
Salmonella infection
Dopaminergic synapse
Regulation of actin cytoskeleton
Hippo signaling pathway
Oxytocin signaling pathway
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ID

P-value
4080
4512
4723
5146
4510
4060
4727
4020
4724
5032
4360
5412
4668
4725
4010
5414
4940
5332
4713
5144
5133
4151
5330
4970
5217
4726
4911
4610
5205
4015
5320
5142
4024
5321
5132
4728
4810
4390
4921

3.07329287027726E-024
2.25446129029711E-013
4.43031313777547E-013
2.35926409508521E-009
4.10468848356526E-009
1.04082432754351E-008
1.96616241871058E-007
2.66433290189066E-007
2.99528714194504E-007
1.46223552153929E-006
2.56154461772565E-006
5.80070885088937E-006
7.05185589718525E-006
8.26225960794004E-006
8.87554095726216E-006
1.87259156594522E-005
2.85272365542126E-005
3.15412642468037E-005
4.00104798322369E-005
7.37367878833327E-005
7.53646929915071E-005
7.76447121553292E-005
9.29467049479692E-005
0.0001208929
0.0001222042
0.0001521034
0.0001853173
0.0001913106
0.0001968632
0.0002765209
0.0003248347
0.0005336405
0.0008440887
0.0008758181
0.0010872948
0.0010937157
0.0013167783
0.00136708
0.0014231938

Melanogenesis
Vascular smooth muscle contraction
Viral myocarditis
Platelet activation
Chemokine signaling pathway
Antigen processing and presentation
Type II diabetes mellitus
Amyotrophic lateral sclerosis (ALS)
Ras signaling pathway
HTLV-I infection
Rheumatoid arthritis
Tuberculosis
African trypanosomiasis
Legionellosis
Leukocyte transendothelial migration
NOD-like receptor signaling pathway
Leishmaniasis
Pancreatic secretion
Non-alcoholic fatty liver disease (NAFLD)
Toll-like receptor signaling pathway
Estrogen signaling pathway

4916
4270
5416
4611
4062
4612
4930
5014
4014
5166
5323
5152
5143
5134
4670
4621
5140
4972
4932
4620
4915

0.0016116522
0.0024985923
0.0025731315
0.002956751
0.0031712004
0.0032967821
0.0045364104
0.0048212234
0.0053916726
0.005856462
0.0068452163
0.0069668622
0.0071106286
0.013234652
0.0169926319
0.024776298
0.0254243775
0.0259565609
0.031489168
0.0419067619
0.044560232

Table 4-5: SPIA pathway enrichment results between astrocytes and neurons. This table shows
the names of all pathways significantly enriched between the two samples to a significance level
of p<0.05. This p-value is calculated by combining the p-values of the numbers of DEGs with
the p-value of the accumulation of perturbation in the pathway.
Several of these pathways were selected for further exploration, research, and explanation
in order to provide a coherent view at why the cells present different transcriptomes in the
manner shown above. The pathways selected for closer examination were done so on the basis of
high significance, and previously found evidence of these pathways being involved in the cell
types in question. The pathways examined for this comparison are the calcium signaling
pathway[Grewal et al., 1999] (figure 4-6) and ECM-receptor interaction [Milner et al., 2002]
(figure 4-7). Other pathways are also presented in Appendix A- for citations ergarding the
pathways, see the KEGG page for the pathway. In these charts, red-colored genes indicate those
genes with increased expression in astrocytes, while blue indicates increased expression in
neurons. In many cases the results are self-explanatory- in figure 4-6, many genes which show
increased expression in neurons are genes related to the production of calcium ions, which are
needed for the membrane depolarization of an action potential. This pathway has previously been
shown to be significantly enriched in neurons [Cahoy et al., 2008]. Data in the opposite direction
is illustrated in Figure 4-9, which shows how many other genes involved with ECM interaction
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Figure 4-6: Difference in expression of the calcium signaling pathway between astrocytes and
neurons in rat cells in vitro. Red indicates genes more expressed in astrocytes, blue in neurons.
Figure 4-7: Difference in
expression of the ECMreceptor interaction
pathway between
astrocytes and neurons in
rat cells in vitro. Red
indicates genes more
expressed in astrocytes,
blue in neurons.
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are also upregulated in astrocytes.
A similar analysis was carried out comparing astrocytes with OPCs. The GAGE and
SPIA pathways are shown in tables 4-6 and 4-7 respectively.
Pathway
rno04510 Focal adhesion
rno04512 ECM-receptor interaction
rno04060 Cytokine-cytokine receptor interaction
rno04610 Complement and coagulation cascades
rno04640 Hematopoietic cell lineage
rno05332 Graft-versus-host disease
rno05330 Allograft rejection
rno05146 Amoebiasis
rno05320 Autoimmune thyroid disease
rno04145 Phagosome
rno04612 Antigen processing and presentation
rno05416 Viral myocarditis
rno05144 Malaria
rno00982 Drug metabolism - cytochrome P450
rno05150 Staphylococcus aureus infection
rno04142 Lysosome
rno05323 Rheumatoid arthritis
rno04670 Leukocyte transendothelial migration
rno00980 Metabolism of xenobiotics by cytochrome P450
rno04672 Intestinal immune network for IgA production
rno04380 Osteoclast differentiation
rno05410 Hypertrophic cardiomyopathy (HCM)
rno04940 Type I diabetes mellitus
rno05140 Leishmaniasis
rno00590 Arachidonic acid metabolism
rno04350 TGF-beta signaling pathway
rno04514 Cell adhesion molecules (CAMs)
rno04620 Toll-like receptor signaling pathway
rno04974 Protein digestion and absorption
rno05142 Chagas disease (American trypanosomiasis)
rno04630 Jak-STAT signaling pathway
rno04810 Regulation of actin cytoskeleton
rno00480 Glutathione metabolism
rno05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
rno05145 Toxoplasmosis
rno05414 Dilated cardiomyopathy
rno00830 Retinol metabolism
rno00860 Porphyrin and chlorophyll metabolism
rno00140 Steroid hormone biosynthesis
rno04621 NOD-like receptor signaling pathway
rno04520 Adherens junction
rno05200 Pathways in cancer
rno04144 Endocytosis
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p.val
3.00701222955865E-007
1.28038900882564E-006
2.28727074980988E-006
2.54772957541032E-006
1.02271209601321E-005
1.82171947975172E-005
2.58888215887163E-005
2.73669027128534E-005
0.000032462
4.38606182660206E-005
5.37177881070096E-005
9.70088097394853E-005
0.0001304827
0.0001701415
0.0002846929
0.00030002
0.0006468994
0.0006725302
0.0006971917
0.0043414118
0.0044443855
0.0044692347
0.004522284
0.004660193
0.0048615008
0.0049777852
0.005765729
0.0061245437
0.0071957618
0.0076378745
0.0096987157
0.0108520136
0.0123689614
0.0201503474
0.0226864679
0.0253738442
0.0256751099
0.0268112379
0.0277690325
0.0278486375
0.0279745708
0.0293339627
0.0342456514

rno00983 Drug metabolism - other enzymes
rno04623 Cytosolic DNA-sensing pathway
rno00531 Glycosaminoglycan degradation

0.0424704825
0.0466000052
0.049300726

Table 4-6: GAGE pathway enrichment results between astrocytes and OPCs. This table shows
the names of all pathways significantly enriched between the two samples to a significance level
of p<0.05.
Name
Focal adhesion
Cytokine-cytokine receptor interaction
ECM-receptor interaction
Neuroactive ligand-receptor interaction
PI3K-Akt signaling pathway
Complement and coagulation cascades
Amoebiasis
Proteoglycans in cancer
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Antigen processing and presentation
Malaria
Axon guidance
Graft-versus-host disease
Basal cell carcinoma
TNF signaling pathway
Regulation of actin cytoskeleton
Hippo signaling pathway
Allograft rejection
Ras signaling pathway
Autoimmune thyroid disease
Viral myocarditis
Legionellosis
Type I diabetes mellitus
Dilated cardiomyopathy
Pertussis
MAPK signaling pathway
Rap1 signaling pathway
Rheumatoid arthritis
Calcium signaling pathway
Chemokine signaling pathway
HTLV-I infection
Platelet activation
GABAergic synapse
Gap junction
Staphylococcus aureus infection
Pancreatic secretion
Hedgehog signaling pathway
Leukocyte transendothelial migration
Inflammatory bowel disease (IBD)
Melanogenesis
Natural killer cell mediated cytotoxicity
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ID

p-value
4510
4060
4512
4080
4151
4610
5146
5205
5412
4612
5144
4360
5332
5217
4668
4810
4390
5330
4014
5320
5416
5134
4940
5414
5133
4010
4015
5323
4020
4062
5166
4611
4727
4540
5150
4972
4340
4670
5321
4916
4650

1.38421519222539E-012
1.56229538911204E-011
2.32622324869824E-011
4.33274515838219E-011
0.000000746
1.40052531449438E-006
2.6970744833687E-006
3.38384221895463E-006
8.61005720039904E-006
1.07834042730725E-005
0.000056907
0.0001733176
0.000184766
0.0002114821
0.0002252596
0.0002259169
0.000302097
0.0005431512
0.0005869827
0.0014404913
0.0016006053
0.0016832378
0.0019730011
0.0022785193
0.0022844431
0.0038695569
0.0045789606
0.0062671987
0.0063625318
0.0096508288
0.0167475713
0.020458923
0.022860501
0.0231986574
0.0323132351
0.0375959972
0.0381421595
0.0384666556
0.0464805379
0.0488556064
0.0495719618

Figure 4-8: Difference in
expression of the ECMreceptor interaction
pathway between astrocytes
and OPCs in rat cells in
vitro. Red indicates genes
more expressed in
astrocytes, blue in OPCs.

Figure 4-9:
Difference in
expression of
cell-cycle-related
genes between
astrocytes and
OPCs in rat cells
in vitro. Red
indicates genes
more expressed
in astrocytes,
blue in OPCs.
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Table 4-7: SPIA pathway enrichment results between astrocytes and OPCs. This table shows the
names of all pathways significantly enriched between the two samples to a significance level of
p<0.05. This p-value is calculated by combining the p-values of the numbers of DEGs with the
p-value of the accumulation of perturbation in the pathway.
It should be noted that several of the same pathways are significantly different in this
comparison as when comparing astrocyte/neuron expression. In particular, the ECM-receptor
interaction (figure 4-8) pathway is very similar when comparing which genes are different, and
how different they are. This means that the genes represented in those pathways as upregulated
are indeed upregulated in that cell type compared to all of the neural cells measured, rather than
simply downregulated in one of the cell types it is compared to. Additionally, the pathway for
the cell cycle is shown in figure 4-9, and it can be clearly seen that OPCs have a far more active
cell cycle than astrocytes, something which also follows logically- as a type of semidifferentiated stem cell, OPCs are able to generate certain types of glial cells while themselves
continuing to reproduce and self-sustain, constituting a source of fresh cells for myelination and
other functions. It is to be expected that OPCs are more reproductively active than astrocytes
[Richardson et al., 2011].
The third comparison conducted between expression of cell types in in vitro neural tissue
in rat is between neurons and OPCs. Similarly to the first two comparisons illustrated above,
GAGE and SPIA were used to find significantly different pathways. These results are shown in
tables 4-8 and 4-9 respectively.
Pathway
rno04080 Neuroactive ligand-receptor interaction
rno04020 Calcium signaling pathway
rno04360 Axon guidance
rno04010 MAPK signaling pathway
rno04971 Gastric acid secretion
rno04640 Hematopoietic cell lineage
rno04540 Gap junction
rno04970 Salivary secretion
rno00140 Steroid hormone biosynthesis
rno05410 Hypertrophic cardiomyopathy (HCM)
rno05150 Staphylococcus aureus infection
rno05414 Dilated cardiomyopathy
rno05014 Amyotrophic lateral sclerosis (ALS)
rno04930 Type II diabetes mellitus
rno04720 Long-term potentiation
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p.value
1.83537649987241E-007
9.65126868231387E-005
0.0001890481
0.0052474724
0.0166362574
0.0210286796
0.0270465037
0.028864329
0.0308472775
0.0314395578
0.0350717493
0.0397656662
0.0426826103
0.0463752297
0.047943512

rno04742 Taste transduction

0.048158335

Table 4-8: GAGE pathway enrichment results between neurons and OPCs. This table shows the
names of all pathways significantly enriched between the two samples.
Name
Neuroactive ligand-receptor interaction
Axon guidance
Retrograde endocannabinoid signaling
Ras signaling pathway
Glutamatergic synapse
ECM-receptor interaction
Serotonergic synapse
Focal adhesion
Morphine addiction
GABAergic synapse
Dopaminergic synapse
Gap junction
Calcium signaling pathway
Cocaine addiction
Circadian entrainment
Long-term depression
Oxytocin signaling pathway
PI3K-Akt signaling pathway
Cholinergic synapse
cAMP signaling pathway
Insulin secretion
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Amphetamine addiction
Aldosterone-regulated sodium reabsorption

ID

p-value
4080
4360
4723
4014
4724
4512
4726
4510
5032
4727
4728
4540
4020
5030
4713
4730
4921
4151
4725
4024
4911
5412
5031
4960

6.33267599521586E-011
4.29723503574245E-010
7.9007375830512E-006
0.0001183561
0.0001731923
0.0006506711
0.0007915077
0.0008611562
0.0010781791
0.0037976955
0.0041635117
0.0048873919
0.0050331302
0.0067965308
0.0101038035
0.0122826349
0.0153835989
0.0170602811
0.020617422
0.0238893909
0.0291954252
0.034318422
0.0420889789
0.0474884126

Table 4-9: SPIA pathway enrichment results between neurons and OPCs. This table shows the
names of all pathways significantly enriched between the two samples to a significance level of
p<0.05. This p-value is calculated by combining the p-values of the numbers of DEGs with the
p-value of the accumulation of perturbation in the pathway.
The pathway charts for calcium signaling, and the cell cycle are shown below in figures
4-10, and 4-11. The gene expression patterns in the calcium signaling and axon guidance charts
show that these genes are indeed upregulated in neurons compared to the other cell types
examined, and the expression in the cell cycle pathway shows that OPCs are indeed much more
active in the cell cycle than either other cell type examined. It should be noted that in this
comparison, neither GAGE nor SPIA indeed found the cell cycle to be significantly enrichedhowever, the genes shown within it in figure 4-15 are all significant to a level of q < 0.05, and so
the genes involved may be used to illustrate differences in expression between the two cell types
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Figure 4-10: Difference in expression of the calcium signaling pathway between neurons and
OPCs in rat cells in vitro. Red indicates genes more expressed in neurons, blue in OPCs.
Figure 4-11:
Difference in
expression of
cell-cycle-related
genes between
neurons and
OPCs in rat cells
in vitro. Red
indicates genes
more expressed
in neurons, blue
in OPCs.
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despite the pathway itself not making the statistical cut.

E) In vitro/ in vitro comparison: Consistency between published annotation and crossspecies annotation
The basis of the cross-species comparisons made later within this manuscript hinge upon
the assumption that the orthology-based cross-species annotation generated for the non-mouse
species does in fact accurately represent the expression within the samples tested. To illustrate
the consistency of results derived from this generated annotation, the comparisons mentioned
above have been repeated using said annotation, and the orthologous KEGG pathways in mouse
have been colored with expression values by cell type. It is to be expected that the pathways
from the cross-species annotation will have fewer genes shown as differentially expressed, as
significant numbers of genes and exons were cut from the mm10 annotation which served as its
basis. Comparing figure 4-6 to figure 4-12, figure 4-7 to figure 4-13, and so on, it can be seen
that among those genes which were indeed conserved during the generation of the cross-species
annotation, expression within pathways is shown to be highly consistent. This is mildly further

Figure 4-12: Difference in expression of the calcium signaling pathway between astrocytes and
neurons in rat cells in vitro, using the cross-species annotation. Red indicates genes more
expressed in astrocytes, blue in neurons.
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Figure 4-13: Difference
in expression of the
ECM-receptor
interaction pathway
between astrocytes and
neurons in rat cells in
vitro using the crossspecies annotation. Red
indicates genes more
expressed in astrocytes,
blue in neurons.

Figure 4-14:
Difference in
expression of the ECMreceptor interaction
pathway between
astrocytes and OPCs in
rat cells in vitro using
the cross-species
annotation. Red
indicates genes more
expressed in astrocytes,
blue in OPCs.
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Figure 4-15: Difference in expression of cell-cycle-related genes between astrocytes and OPCs
in rat cells in vitro using the cross-species annotation. Red indicates genes more expressed in
astrocytes, blue in OPCs.

Figure 4-16: Difference in expression of the calcium signaling pathway between neurons and
OPCs in rat cells in vitro using the cross-species annotation. Red indicates genes more
expressed in neurons, blue in OPCs.
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Figure 4-17: Difference in expression of cell-cycle-related genes between neurons and OPCs in
rat cells in vitro using the cross-species annotation. Red indicates genes more expressed in
neurons, blue in OPCs.
supported by a similar comparison using human data in the next section. Furthermore, all of the
pairwise pathway comparisons selected and shown here were indeed significantly (p < 0.05)
differently expressed between the cell types in question using the cross-species annotation.
F) In vitro/ in vitro comparison: Differences in expression between in vitro human neural
cells
The human samples were quantified against the hg38 annotation, and then compared
against one another to quantify the differences in expression. Unlike the rat data, which had six
samples across three difference cell types, the human data only has three samples across two cell
types- two samples of astrocytes, and one of neurons. Since only one comparison- astrocyte
versus neuron- can be made, a truncated version of the same analyses applied to the rat data were
applied to these samples. The top 200 genes expressed in the human samples were identified, and
a heatmap of these was produced, grouping rows by similarity of expression across columns.
This heatmap is shown in figure 4-26. Additionally, a heatmap was made of the 40 most
significantly differentially expressed genes comparing the two cell types, showing the 20 most
significant genes in each direction, shown in figure 4-27. Since there is only one comparison,
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Figure 4-18: Difference in expression of the calcium signaling pathway between astrocytes and
neurons in human cells in vitro. Red shows genes more expressed in astrocytes, blue in neurons.
Figure 4-19:
Difference in
expression of the
ECM-receptor
interaction pathway
between astrocytes and
neurons in human cells
in vitro. Red indicates
genes more expressed
in astrocytes, blue in
neurons.
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Figure 4-20: Difference in expression of the calcium signaling pathway between astrocytes and
neurons in human cells in vitro using the cross-species annotation. Red indicates genes more
expressed in astrocytes, blue in neurons.
Figure 4-21: Difference
in expression of the
ECM-interaction
pathway between
astrocytes and neurons
in human cells in vitro
using the cross-species
annotation. Red
indicates genes more
expressed in astrocytes,
blue in neurons.
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unlike the rat data, it does not make sense to create Venn diagrams.

G) In vitro/ in vitro comparison: Pathway analysis of differences between in vitro cell types
in humans
A pathway analysis was done to compare the expression data between the in vitro
astrocyte and neuron samples of human data to quantify differences in expression in terms of
biological processes. Significantly enriched KEGG pathways between astrocytes and neurons
were tested using both SPIA and GAGE, and these pathways were then visualized using
Pathview. Scraw. Several of these pathways were then selected for display and further
examination. In an effort to show the similarity of expression between cell types across species
in vitro, the same four pathways have been chosen for display as were shown in the rat samples
between astrocytes and neurons: calcium signaling (figure 4-18) and ECM-receptor interaction
(4-19). Additionally, table 4-10 and table 4-11 show the names and p-values of significantly
enriched pathways according to GAGE and SPIA respectively.
Pathway
hsa05200 Pathways in cancer
hsa04510 Focal adhesion
hsa04350 TGF-beta signaling pathway
hsa05222 Small cell lung cancer
hsa05146 Amoebiasis
hsa04530 Tight junction
hsa04630 Jak-STAT signaling pathway
hsa04012 ErbB signaling pathway
hsa04810 Regulation of actin cytoskeleton
hsa04916 Melanogenesis
hsa04020 Calcium signaling pathway
hsa04520 Adherens junction
hsa05414 Dilated cardiomyopathy
hsa04270 Vascular smooth muscle contraction
hsa04210 Apoptosis
hsa05215 Prostate cancer
hsa04512 ECM-receptor interaction
hsa04310 Wnt signaling pathway
hsa04910 Insulin signaling pathway
hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
hsa04972 Pancreatic secretion
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p.value
1.63719714996876E-023
1.33442952320779E-009
6.31310896544157E-009
5.96155427648299E-007
1.12776895084513E-005
0.0001840087
0.0005678789
0.0008353908
0.0009685493
0.0018775965
0.0021094405
0.0023267521
0.0023267521
0.0023267521
0.004033723
0.0041631424
0.0048975472
0.006808502
0.0161831421
0.0188977142
0.0194438063

hsa04070 Phosphatidylinositol signaling system
hsa05220 Chronic myeloid leukemia
hsa05410 Hypertrophic cardiomyopathy (HCM)
hsa04062 Chemokine signaling pathway

0.020235566
0.0317978025
0.0355845124
0.0366130368

Table 4.10: Pathway names and p-values for significantly enriched pathways between astrocytes
and neurons in humans according to GAGE

Name
Huntington's disease
Parkinson's disease
Alzheimer's disease
Regulation of actin cytoskeleton
Bladder cancer
Non-alcoholic fatty liver disease (NAFLD)
Focal adhesion
Pathogenic Escherichia coli infection
Proteoglycans in cancer
Rheumatoid arthritis
Antigen processing and presentation
Staphylococcus aureus infection
MAPK signaling pathway
Renal cell carcinoma
Glioma
Vasopressin-regulated water reabsorption
FoxO signaling pathway
Pathways in cancer
Melanoma
MicroRNAs in cancer
Axon guidance
Gap junction
Dorso-ventral axis formation
Systemic lupus erythematosus
TGF-beta signaling pathway
Long-term depression

ID

p-value
5016
5012
5010
4810
5219
4932
4510
5130
5205
5323
4612
5150
4010
5211
5214
4962
4068
5200
5218
5206
4360
4540
4320
5322
4350
4730

6.94683003081565E-010
8.86828526568921E-008
0.0001990188
0.0004715822
0.0013795331
0.0015988699
0.0045914426
0.0058208172
0.0060250334
0.0075895909
0.0089817593
0.0104012927
0.0141833249
0.0147375044
0.0222826613
0.0228327459
0.0248485374
0.0268508511
0.0273761102
0.0300794915
0.0317007079
0.0355358689
0.0385288448
0.0417056628
0.0454233583
0.0456562565

Table 4-11: SPIA pathway enrichment results between astrocytes and neurons in humans. This
table shows the names of all pathways significantly enriched between the two samples to a
significance level of p<0.05. This p-value is calculated by combining the p-values of the
numbers of DEGs with the p-value of the accumulation of perturbation in the pathway.
These KEGG pathways were also visualized between the same samples, using the crossspecies comparison generated for humans. However, there are some differences from the similar
comparison made above with rat cells. There are quite a few fewer genes mapping to pathways
than with the rat cross-species annotation, and the magnitude and sometimes even directionality
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of the DEGs shown based on the cross-species annotation is different from the pathways
generated using the hg38 annotation as above. Additionally, none of the four pathways above
were significant using the cross species comparison- the pathway heatmaps were generated by
manually entering the relevant pathway IDs. However, all genes colored on the pathway maps
are indeed all significant to a q-value < 0.05. These pathway charts are the same respective
pathways as above, and can be found in figures 4-18 through 4-21.
H) In vitro/ in vitro comparison: Summary
Based on the comparisons made, it can be shown that the expression between and within
the cell types presented is consistent with previously published comparisons between these cell
types, displaying marker genes and pathways which are known to be expressed in those cell
types. The pathway differences make sense from a biological standpoint, both among those
selected for diagram display as well as the other highly significant pathways. Furthermore, the
pathway analysis and DEGs were shown to be quite similar in the rat comparison between the
rnor5 gene annotation and the cross-species annotation, showing that the process for generating a
cross-species annotation works well at least within the rat samples- the human samples show
markedly less similarity between the hg38 annotation results and the cross-species annotation
results- this may indicate that humans are evolutionarily too far from rats and mice to reliably
generate a high-quality cross-species genome annotation based on orthologous genome positions.
While other methods [Miller et al., 2010] have compared between mice and humans, their
methods for finding consensus were different and less sensitive to evolutionary distance. For this
reason, during the final comparisons between in vitro and in vivo, results and pathways will be
shown only for the rat in vitro and mouse in vivo cells, after correcting for species-wide biases.
Data for the comparison including humans will be shown in Appendix A.
I) In vitro/ in vivo comparison: Differences in gene expression between in vitro and in vivo
Once features were counted, the top 40 genes for each cell type within each species examined
were found. Genes were sorted by log fold change, and genes with low expression were filtered
out by selecting only genes which had a logCPM greater than 1.3, equivalent to a CPM of around
20. In the species with more than two cell types, the fold change was calculated by combining
the expression data for all cell types which were not the one of interest. These top genes per cell
type by species are presented in Table 4-12.
Presented in figure 4-22 are heatmaps representing the expression among all cell types
60

Figure 4-22 A: The top 200 genes by
absolute expression across the
experiment were selected, and the
expression values for each is shown of
all cell types. Rows and columns are
ordered by similarity.

Figure 4-22 B: The top 200 genes by
absolute expression across the
experiment were selected, and the
expression values for each is shown
of each data sample. Rows and
columns are ordered by similarity.
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and samples respectively. In both figures, the 200 genes with the highest expression across the
whole experiment are shown , with their expression levels in each column shown by color. Both
rows and columns are grouped by overall similarity, illustrated with a dendrogram. The black
lines on each cell is merely a histogram, providing an additional visualization of the value of
each cell to complement its color. The figures illustrate visible differences between samples and
species, and may also be used to double-check the quality of the data- if a sample is
exceptionally different from others in its group, it may be a target for additional scrutiny. This is
mainly useful for assessing consistency within species among the most highly expressed genes
and visualizing how different expression patterns in the other species are.
rn.Astrocyte rn.Neuron
Tnn
Neurod6
Gm29233
Slc17a7
C1ra
Zfp804a
Clec2d
Cck
Ccl7
Hs3st5
Arsi
Gm26755
Ahnak
4930461C15Rik
Cnn1
Elmod1
Thbs2
Sst
Hsp25-ps1 Cbln2
Col14a1
Cyp2c54
Fam26e
Olfr821
Hspb2
St8sia2
Serpina3d-ps Syt4
Cyr61
Gm13112
Npvf
Gm17019
Lmod1
Neurod2
Fbln5
Golga7b
Mug1
Camkv
A2m
Dync1i1
Serpina3e-ps AI606181
Gldn
Mir124a-2
Lgals1
Utp3
Cebpd
Rprm
Serpina3f
Asphd1
Thbd
Gm26794
Itga11
B3galt2
Mfap4
Ddn
Mug2
Cyp4x1os
B3gnt8
Mir132
Mxra8os
Gm3027
n-R5s159
Fam163b
Serpina3n Sla
Serping1
Gm867
Fibin
Slc17a6
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rn.OPC
mm.Astrocyte mm.Neuron
mm.OPC
hg.Astrocyte
hg.Neuron
Neu4
Vmn2r55
Gm27404
Sco1
Ssr2
Gm10384
Lims2
Ly75
2210010C04Rik Abcf2
Pkp1
Cyth2
Fam89a
Srsf6
Cbwd1
Oxr1
Gm17234
Atf5
Dmrtb1
Gm11750
Gm13848
Triap1
Slc16a7
Cct2
Bcas1os2
Vmn2r26
Zfp804b
Olfr969
Rarres1
Zfp706
Gal3st1
Gm5943
Gm11571
Pdzd9
Gm15008
Hao2
Pnlip
Cacybp
Scarna10
Crygb
Gm5457
Fam57b
Rlbp1
Epcam
Gm10163
Ric8b
Gm28610
Polr3d
Ugt8a
Ccl26
Gm28539
Smagp
Gm21885
Gm6272
Gm5227
Ccdc89
Gm11842
Gm21392
Cep135
Mthfd2l
Bcas1os1
Cep152
Gcm1
Fcrls
Vmn1r-ps48
Ces2e
Cdh19
Stoml3
Clasrp
Mir6405
Pan2
Prss23
6430503K07Rik Dzank1
Gm13436
4930538K18Rik Olfr718-ps1
Gm3222
Trav3n-3
Dapk1
Gm25621
Rfx8
Olfr1063-ps1
Rpl35a-ps7
Ctrb1
Atoh8
Fbxw15
Stk32a
Spata18
Wdr60
Slc35d3
2900026A02Rik Pstpip2
Zfp169
Ddb2
Gm26956
Nkx2-2os
Ppme1
Ficd
Rabac1
Gm23033
Gm13601
Olig1
Wdr48
Tnni3k
Gm20753
Gm6298
Odc1
Olig2
Psmd9
9030624G23Rik Gm26807
Stc1
Kctd4
Neto1
Ube2n
Trav4n-3
Gm12030
Slc8a2
Crym
Ano3
Gm15540
Ccdc177
Hist1h2an
4930554C24Rik Best3
Smoc1
Ddx17
Gm16429
Ofcc1
Gm11693
Gm15332
Olig3
Gm16585
Gm9568
Cdyl
Erh
Pik3c3
Gm13031
Fam84a
Snrpd1
Mir218-1
Gm5072
Ecsit
Gm26568
Traf2
B3galnt1
Slc39a1
Kcnk7
Vps37c
Tgfa
Gm28609
Gm14847
Gm29465
Dkk3
Pcsk2os1
Pmel
Ap1ar
Gssos1
Pdgfra
Crbn
Rpl23a-ps14
Spon1
Vmn1r-ps11
Frrs1
Fzd1
Lyrm4
Gm13192
Trav3d-3
Gm5759
Hyal2
Lonrf2
Bicc1
Rpl21-ps13
Gm12146
Sdad1
Klrc1
Dpep3
Olfr876
Gm11425
Gm10259
Hist1h2bn
Ift43
Gm27919
Gm14963
Pde12
Pstpip2
Gm28560
Rarres1
Gm24412
Foxd2
Gm2056
Zfp648
Ndufb3
Gm11584
Ghrh
Gm23363
Matn3
Elfn2
Reg3d
Gm29240
Gm6116
Prkacb
Kctd20
Slitrk3
NA
NA
Samd1
Gm15382
Psca

Aldh1a7
Il1r1
Serpina3c
Aldh1a1
Lyve1

Npas4
Enpp2
Got1l1
Olfr691
5730559C18Rik Rprm
4930506M07RikCspg4
Cdc42
Kcnk9
Sox10
Gm26995
Gm20387
Gm27617
Rpl27-ps1

Igkv11-125
Gm13248
Tmem252
Gm20397
Gm11817

Cpsf7
Ints1
Dtl
Gm12770
Gm26794
Gm28289
1700086O06Rik Gm12632
Olfr197
Gdf6

Atp13a1
Icam4
Gm24649
Slc20a2
Slc7a11

Table 4-12: The top 40 genes expressed in each cell type compared against all other cell types
within its species, sorted by log fold change. Genes with total expression logCPM less than 1.3
have been removed.
Showing the top expressed genes for samples only illustrates certain aspects about that
sample. When comparing samples to one another, it can be much more useful to compare the
lists of all significantly differently expressed genes between two or more comparisons. Looking
at the lengths of lists of DEGs can show at a glance whether two samples are distant from one
another (and therefore have relatively high numbers of DEGs) or are more similar, and have
fewer DEGs. These numbers can themselves be compared as well, using Venn diagrams for
example. While simple overlap comparisons are not statistically rigorous and do not provide a
quantitative measure of distance between two samples, Venn diagrams are very easy and intuitive
to understand and can then be used to illustrate interesting aspects of the data. Table 4-13 shows
a number of comparisons with the numbers of differentially expressed genes between them, and
Figure 4-23 contains Venn Diagrams showing the quantity of DEGs that some of these
comparisons share. The high number of DEGs which are shared among all cell types in Figure 423 indicate that there is a high degree of conservation among which genes are differentially
expressed in vitro versus in vivo, implying that the difference affects the different cell types in
much the same way. Note how in the species-corrected charts and tables, this is not the case.
Further supporting this is Table 4-14, which shows the number of DEGs for in vitro/in vivo
comparisons of comparisons between cell types within in vitro or in vivo. That is, for example, in
vitro astrocytes and neurons are compared to one another, and in vivo astrocytes and neurons are
compared to one another. The results of these two comparisons are compared to each other for
DEGs. This controls for the average differences between settings for the cell types examined,
revealing which differences between cell types are not preserved across settings. A positive log
fold change for a gene in the above example means that it is more expressed in in vitro astrocytes
or in vivo neurons than the other two cell types, and the inverse for a negative log fold change.
The Venn diagrams in Figure 4-24 show how these data are consistent for each cell type.
Essentially, what is shown here indicates that while many of the same genes are differentially
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expressed in an in vitro setting compared to the same cell type in vivo in all three cell types, those
genes are differently expressed at significantly different levels across cell types.
In vitro vs in vivo

All cell types

Astrocyte

Neuron

OPC

Total DEGs

11830

11835

11497

12832

More expressed in vitro

4793

5122

4729

6642

More expressed in vivo

7037

6713

6768

6190

Table 4-13 A: The numbers of DEGs (q < 0.05) between in vitro and in vivo cell types, as well as
all cell types combined. The total number of DEGs is shown, and then broken down by the
direction in which they are differently expressed.
R. norvegicus vs M. musculus

All cell types

Astrocyte

Neuron

OPC

Total DEGs

13748

12970

13219

12832

More expressed in vitro

7101

6708

6791

6642

More expressed in vivo

6647

6262

6428

6190

Table 4-13 B: The numbers of DEGs (q < 0.05) between in vitro and in vivo cell types,as well as
all cell types combined, excluding human data. The total number of DEGs is shown, and then
broken down by the direction in which they are differently expressed.
R. norvegicus vs M. musculus, species-corrected

Astrocyte

Neuron

OPC

Total DEGs

2807

2571

1778

More expressed in vitro

1477

1096

813

More expressed in vivo

1330

1475

965

Table 4-13 C: The numbers of DEGs (q < 0.05) between in vitro and in vivo cell types in rats and
mice corrected for average species differences. The total number of DEGs is shown, and then
broken down by the direction in which they are differently expressed.
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Figure 4-23: These Venn diagrams compare the DEGs shown in Table 4-13, showing the number
of DEGs in common among the different comparisons. The top row shows the genes upregulated
in the in vitro/in vivo, rat/mouse, and corrected rat/mouse comparisons respectively. The bottom
row shows genes downregulated in those same comparisons.
In vitro vs in vivo

Ast vs Neu

Ast vs OPC

Neu vs OPC

Total DEGs

1940

5098

5175

Log FC > 0

1248

1719

1549

Log FC < 0

692

3379

3626

Table 4-14 A: The number of DEGs which are different between settings when comparing the
results of comparisons between cell types within settings.
R. norvegicus vs M. musculus

Ast vs Neu

Ast vs OPC

Neu vs OPC

Total DEGs

3042

2343

1887

Log FC > 0

1651

1256

915

LogFC < 0

1391

1087

972

Table 4-14 B: The number of DEGs which are different between settings when comparing the
results of comparisons between cell types within settings, using only rat and mouse data.
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A)

B)

C)

D)

Figure 4-24: These Venn diagrams show similarities between comparisons between settings of
comparisons across cell types within settings. In (A), the number shown is the number of genes
significantly upregulated in the first cell type in vitro or the second cell type in vivo, while (B)
shows the genes significantly upregulated in the second cell type in vitro or the first cell type in
vivo. (C) and (D) show the same data as (A) and (B) respectively, but limit the in vitro data to
only the rat datasets.
J) In vitro/ in vivo comparison: Pathway analysis of differences between settings in neural
tissue: Astrocytes
The same analysis pipelines were used for downstream analysis here as were applied in
earlier sections, and these results will be formatted similarly. There will also be presentation of
some additional data to support certain observations made with regard to previously published
data. First, GAGE and SPIA were used to examine significantly enriched pathways between the
settings, the results of which are presented in table 4-15 and table 4-16 respectively.
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Name
mmu04510 Focal adhesion
mmu04512 ECM-receptor interaction
mmu05322 Systemic lupus erythematosus
mmu05410 Hypertrophic cardiomyopathy (HCM)
mmu00590 Arachidonic acid metabolism
mmu04380 Osteoclast differentiation
mmu05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
mmu00512 Mucin type O-Glycan biosynthesis
mmu05144 Malaria
mmu04142 Lysosome
mmu05142 Chagas disease (American trypanosomiasis)
mmu04350 TGF-beta signaling pathway
mmu04610 Complement and coagulation cascades
mmu05150 Staphylococcus aureus infection
mmu05323 Rheumatoid arthritis
mmu04060 Cytokine-cytokine receptor interaction
mmu04623 Cytosolic DNA-sensing pathway

p.value
0.0008373788
0.0011940708
0.0017702126
0.0116477713
0.0142221262
0.014404177
0.014470395
0.0149552317
0.0160004138
0.0225967975
0.0272777774
0.0273757933
0.0346088745
0.0397687685
0.0445840522
0.0464504089
0.0478515833

Table 4-15: GAGE pathway enrichment results between in vitro rat cells and in vivo mouse cells
in astrocytes, corrected for species averages. This table shows the names of all pathways
significantly enriched between the two samples to a significance level of p<0.05.
Name
Leishmaniasis
Focal adhesion
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Malaria
ECM-receptor interaction
Chagas disease (American trypanosomiasis)
TGF-beta signaling pathway
Neurotrophin signaling pathway
Cytosolic DNA-sensing pathway
HTLV-I infection
p53 signaling pathway
Tuberculosis
Salivary secretion
Non-alcoholic fatty liver disease (NAFLD)
Apoptosis
Ras signaling pathway
Transcriptional misregulation in cancer
Proteoglycans in cancer
Prolactin signaling pathway
Pertussis

ID

p-value
5140
4510
5412
5144
4512
5142
4350
4722
4623
5166
4115
5152
4970
4932
4210
4014
5202
5205
4917
5133

0.0029970393
0.0031290533
0.0087905376
0.010428679
0.0138441248
0.0164261482
0.0165152959
0.0216386759
0.0235171382
0.0243480803
0.0267844318
0.0301036627
0.0327244468
0.038339307
0.0392215392
0.0406188981
0.0426365941
0.0429569239
0.0442497033
0.0495088878

Table 4-16 A: SPIA pathway enrichment results between in vitro rat cells and in vivo mouse cells
in astrocytes, corrected for species averages. This table shows the names of all pathways
significantly enriched between the two samples to a significance level of p<0.05.
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Figure 4-25: Difference
in expression in the
ECM-receptor
interaction pathway
between in vitro rat cells
and in vivo mouse cells,
corrected for species
averages. Red shows
genes more expressed in
rats, blue in mice.

Figure 4-27: Differences between
the Notch signalling pathway in in
vitro rat astrocytes and in vivo
mouse astrocytes. Pathway is shown
before species average correction
(top) and after (bottom).
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Two pathways are then selected for closer examination: ECM-receptor interaction (figure
4-25) and notch signaling (figure 4-26). There are several reasons for selecting these pathwaysfirstly, ECM-receptor interaction is selected for the same reason as it was above, thanks to its
known involvement in astrocytes as well as its high significance in tables 4-15 and 4-16. The
notch signaling pathway is chosen because it has previously been examined and discussed across
in vitro/in vivo settings [Cahoy et al., 2008] and the data presented allows for an expansion of
that examination.

The Cahoy paper also published a list of the top 80 genes which were enriched in vitro
over in vivo, and the top 80 enriched in vivo over in vitro. The expression for these genes are
recorded in tables 4-17 and 4-18 respectively. Note that none of the tables containing this
experiment's data lists all 80 genes- this is because not all of the genes of interest were included
in the cross-species annotation.
Gene
ENSMUSG00000033715.9
ENSMUSG00000024989.9
ENSMUSG00000004665.5
ENSMUSG00000029484.8
ENSMUSG00000074802.5
ENSMUSG00000062248.5
ENSMUSG00000024521.7
ENSMUSG00000042115.4
ENSMUSG00000020032.9
ENSMUSG00000049630.5
ENSMUSG00000032085.4
ENSMUSG00000039405.6
ENSMUSG00000047139.8
ENSMUSG00000036169.5
ENSMUSG00000068220.5
ENSMUSG00000035683.8
ENSMUSG00000030208.10
ENSMUSG00000021390.5
ENSMUSG00000026365.10
ENSMUSG00000032487.8
ENSMUSG00000040605.6
ENSMUSG00000039004.5
ENSMUSG00000031740.7
ENSMUSG00000025789.4
ENSMUSG00000037820.10
ENSMUSG00000068196.4
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logFC
logCPM
FDR-adjusted p-value
-12.9124260667
5.2878098927
1.5652654387327E-063
-11.1928321878
7.6243137814
5.39825235234495E-061
9.634304725
6.7949343956
8.65687393049909E-045
-5.6397958897
5.3005766252
2.20841758734692E-040
8.4500205061
4.8245305333
1.00331471517222E-039
-8.5945965819
4.1371425747
7.10014327001427E-037
-7.5144496248
6.2174272664
9.96681288171922E-034
-8.5758326887
8.0813628016
5.16085966070404E-033
-5.4565024049
3.9624845968
3.544878217455E-028
13.2707851365
5.9161667625
7.92460416029225E-018
6.4188282765
3.9058898113
1.12144766399914E-017
9.3301856302
3.1849452392
7.82792826456485E-017
11.4478724137
8.2153427633
6.6023154737699E-016
8.9765343122
1.694938603
9.7186661293364E-016
-5.4409225059
8.3350205816
3.2808846841303E-015
7.9451011766
1.6469104602
2.20179069426831E-012
-4.8137837255
7.0005727794
2.90471736799602E-011
-5.9682171025
0.493274285
1.25240885492321E-010
-5.7745975928
1.4678549699
3.06889219990471E-010
-2.7574472085
5.0657357367
4.35410716750364E-010
2.558003339
4.9100579269
3.33126474241994E-009
7.1141009585
0.1802332822
1.50786849330001E-008
4.9330286713
0.4201243613
8.08351151184224E-008
7.9334201546
3.5037815998
8.97863775086076E-008
-2.8213947936
0.593062513
1.72427483660731E-007
4.8974229098
0.0860197682
1.89155169646703E-007

ENSMUSG00000026051.8
ENSMUSG00000027500.9
ENSMUSG00000037725.7
ENSMUSG00000022206.6
ENSMUSG00000035493.9
ENSMUSG00000039116.4
ENSMUSG00000021186.8
ENSMUSG00000032218.6
ENSMUSG00000024529.8
ENSMUSG00000032291.8
ENSMUSG00000020427.6
ENSMUSG00000038587.8
ENSMUSG00000022033.4
ENSMUSG00000023905.9
ENSMUSG00000043091.8
ENSMUSG00000022324.9

3.6610828775
-4.2339820116
-2.8145135747
4.6647483911
-1.5329665223
2.811949795
-2.1497163983
-0.8950012093
1.0465578606
2.9918186538
0.0179732953
6.7765858215
6.6328002171
7.7788802587
9.587298414
5.3795474931

3.6013611073
-0.7717362906
4.4671241485
-0.3337966294
0.6789820042
5.7859471521
7.761340882
4.7157600458
7.6239506047
1.3596881778
6.6819569728
7.9461559051
3.937189514
5.8327478538
11.8534381549
2.3687385011

1.81284803918474E-006
8.48154232192173E-006
0.0082270412
0.0135367207
0.0253470078
0.0326582196
0.0390090247
0.1936417833
0.8936853309
0.9997141463
0.9997141463
0.9997141463
0.9997141463
0.9997141463
0.9997141463
0.9997141463

Table 4-17A: This table shows the expression of the genes listed by Cahoy as enriched in
astrocytes in vitro. Data is shown for the in vitro/in vivo comparison of astrocytes. A positive
logFC value indicates the gene was found to be more expressed in vitro, and negative in vivo.
Gene
ENSMUSG00000068220.5
ENSMUSG00000038587.8
ENSMUSG00000030208.10
ENSMUSG00000021186.8
ENSMUSG00000026051.8
ENSMUSG00000037725.7
ENSMUSG00000032085.4
ENSMUSG00000024529.8
ENSMUSG00000042115.4
ENSMUSG00000024521.7
ENSMUSG00000020427.6
ENSMUSG00000039116.4
ENSMUSG00000040605.6
ENSMUSG00000074802.5
ENSMUSG00000024989.9
ENSMUSG00000032487.8
ENSMUSG00000021390.5
ENSMUSG00000039004.5
ENSMUSG00000035493.9
ENSMUSG00000032218.6
ENSMUSG00000032291.8
ENSMUSG00000049630.5
ENSMUSG00000022206.6
ENSMUSG00000043091.8
ENSMUSG00000068196.4
ENSMUSG00000062248.5
ENSMUSG00000029484.8
ENSMUSG00000020032.9

70

logFC

logCPM
FDR-adjusted p-value
6.216365452
8.3350205816
2.91975240567769E-038
6.5352832601
7.9461559051
4.43263309028606E-033
5.2763784172
7.0005727794
8.02158809787916E-031
6.3398253017
7.761340882
1.66297337303183E-030
5.5759771113
3.6013611073
3.35142937887659E-020
-4.642180873
4.4671241485
1.09331423181965E-015
4.7802201646
3.9058898113
5.87711866859075E-014
4.1839529946
7.6239506047
4.38653605727117E-012
3.3165738665
8.0813628016
6.84328989430647E-010
2.6357946311
6.2174272664
7.9992543229577E-010
2.9864652593
6.6819569728
2.18147962332473E-009
2.8067292143
5.7859471521
1.26111246863283E-007
2.1166252457
4.9100579269
1.45813965149602E-007
2.3659537883
4.8245305333
4.39036429385385E-005
-1.9312878359
7.6243137814
0.0001099364
1.5809821672
5.0657357367
0.0019189087
-2.4409924081
0.493274285
0.0022824265
2.4876866954
0.1802332822
0.0990762831
0.9799402836
0.6789820042
0.2949865708
-0.8867406012
4.7157600458
0.4278756244
-0.8466473597
1.3596881778
0.5360436062
1.4689355726
5.9161667625
0.5448174769
1.2365156829
-0.3337966294
0.5463050529
1.1178750118
11.8534381549
0.5945768918
0.9310042183
0.0860197682
0.6912265239
-0.7788899951
4.1371425747
0.7487469915
-0.4115781213
5.3005766252
0.8224563037
0.445422646
3.9624845968
0.9261240746

ENSMUSG00000027500.9
ENSMUSG00000026365.10
ENSMUSG00000033715.9
ENSMUSG00000031740.7
ENSMUSG00000037820.10
ENSMUSG00000004665.5
ENSMUSG00000047139.8
ENSMUSG00000036169.5
ENSMUSG00000022324.9
ENSMUSG00000023905.9
ENSMUSG00000025789.4
ENSMUSG00000039405.6
ENSMUSG00000022033.4
ENSMUSG00000035683.8

-0.5037154236
-0.4256682199
-0.5027496733
0.1770678314
-0.1183880474
3.1926783892
2.2875944606
3.3969419937
0.7194356684
2.7779770254
-1.9179369968
4.3373732657
2.5487163097
-1.3709622246

-0.7717362906
1.4678549699
5.2878098927
0.4201243613
0.593062513
6.7949343956
8.2153427633
1.694938603
2.3687385011
5.8327478538
3.5037815998
3.1849452392
3.937189514
1.6469104602

0.9894078129
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139
0.9997531139

Table 4-17B: This table shows the expression of the genes listed by Cahoy as enriched in
astrocytes in vitro. Data is shown for the rat/mouse comparison of astrocytes, corrected for
species averages. A positive logFC value indicates the gene was found to be more expressed in
rats, and negative in mice.
Gene
ENSMUSG00000022658.10
ENSMUSG00000029307.6
ENSMUSG00000029838.8
ENSMUSG00000003974.5
ENSMUSG00000055782.8
ENSMUSG00000068748.4
ENSMUSG00000026697.9
ENSMUSG00000027221.5
ENSMUSG00000021613.8
ENSMUSG00000004892.8
ENSMUSG00000041261.9
ENSMUSG00000001260.6
ENSMUSG00000021364.10
ENSMUSG00000033910.8
ENSMUSG00000018500.2
ENSMUSG00000000402.2
ENSMUSG00000030235.12
ENSMUSG00000020591.10
ENSMUSG00000049612.10
ENSMUSG00000007682.5
ENSMUSG00000026614.6
ENSMUSG00000039037.5
ENSMUSG00000032482.5
ENSMUSG00000033208.7
ENSMUSG00000021536.7
ENSMUSG00000078202.3
ENSMUSG00000000560.5
ENSMUSG00000021719.8
ENSMUSG00000062151.8
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logFC
logCPM
FDR-adjusted p-value
-6.6727298697
4.2397418938
1.57788380281577E-046
-6.3160525038
4.4394598282
2.06937184840839E-046
-6.891370268
10.3692635751
4.78585131338199E-034
4.1130283823
6.7116645402
2.80673426418589E-022
-3.3411043051
4.9687552586
2.9427431028927E-022
11.3450868947
10.8355017925
2.68423787827601E-021
9.0015194901
2.1684287777
7.97325593760521E-020
8.6843590757
4.7607251758
1.18949915098019E-016
9.6576683108
3.0588701405
2.02006255839125E-016
11.982827698
8.9132953999
3.83404466155513E-015
8.0582870067
3.3321797964
1.85257323731813E-013
7.3694871772
0.1673021936
9.34186965012791E-011
7.9313565275
1.5936495513
8.61529246140492E-010
4.6491441016
4.4992582612
1.16125204858473E-009
8.2311365121
0.7815461363
2.14567023931636E-009
5.9702818777
-0.9551855813
0.000005873
2.7509867056
2.5780334819
6.86584394041893E-006
3.8537686296
5.0849245652
2.07787667505154E-005
-4.0720191645
-0.3966031122
4.63627593978514E-005
7.7376126495
3.2105733415
0.0001361552
5.4652325052
4.0238536627
0.0006215707
6.7592615916
1.9532892075
0.0006576552
-1.4539678268
7.7533654822
0.0025634473
1.4699308297
1.5711263893
0.0538141857
-0.7324676713
1.705750307
0.1225627389
-0.5084281857
4.9010968497
0.5560962209
1.9943063175
4.5956491053
0.9997141463
5.338005329
3.2918903881
0.9997141463
4.9355480073
1.8176584953
0.9997141463

ENSMUSG00000050505.6
ENSMUSG00000039194.10
ENSMUSG00000026259.9

3.6420977262
3.7506717842
3.8409646199

5.1406556021
6.1277671588
2.4763759577

0.9997141463
0.9997141463
0.9997141463

Table 4-18A: This table shows the expression of the genes listed by Cahoy as enriched in
astrocytes in vivo. Data is shown for the in vitro/in vivo comparison of astrocytes. A positive
logFC value indicates the gene was found to be more expressed in vitro, and negative in vivo.
Gene
ENSMUSG00000032482.5
ENSMUSG00000021536.7
ENSMUSG00000029307.6
ENSMUSG00000049612.10
ENSMUSG00000078202.3
ENSMUSG00000030235.12
ENSMUSG00000020591.10
ENSMUSG00000027221.5
ENSMUSG00000003974.5
ENSMUSG00000022658.10
ENSMUSG00000029838.8
ENSMUSG00000000560.5
ENSMUSG00000033910.8
ENSMUSG00000068748.4
ENSMUSG00000033208.7
ENSMUSG00000055782.8
ENSMUSG00000000402.2
ENSMUSG00000021613.8
ENSMUSG00000001260.6
ENSMUSG00000026259.9
ENSMUSG00000021364.10
ENSMUSG00000018500.2
ENSMUSG00000039194.10
ENSMUSG00000007682.5
ENSMUSG00000050505.6
ENSMUSG00000041261.9
ENSMUSG00000026697.9
ENSMUSG00000039037.5
ENSMUSG00000021719.8
ENSMUSG00000062151.8
ENSMUSG00000026614.6
ENSMUSG00000004892.8

logFC
logCPM
FDR-adjusted p-value
-3.5480341694
7.7533654822
2.11051819575502E-011
-1.6526741165
1.705750307
0.0005369356
-1.4783104393
4.4394598282
0.0015858896
-1.9761686399
-0.3966031122
0.0148213486
1.5676349947
4.9010968497
0.0366942269
1.266213626
2.5780334819
0.0591519647
-1.5396382277
5.0849245652
0.1472083579
1.8382267115
4.7607251758
0.2558968775
-0.5779553538
6.7116645402
0.2815536082
0.6266014771
4.2397418938
0.3977021235
-0.5815912135
10.3692635751
0.5431815482
-0.7024220233
4.5956491053
0.623464355
-0.6671795814
4.4992582612
0.7323794649
-0.8466287464
10.8355017925
0.9997531139
-0.246303079
1.5711263893
0.9997531139
0.0027165446
4.9687552586
0.9997531139
-0.6298022259
-0.9551855813
0.9997531139
-0.6105486745
3.0588701405
0.9997531139
-0.7924660209
0.1673021936
0.9997531139
-1.7390558259
2.4763759577
0.9997531139
0.016803913
1.5936495513
0.9997531139
2.1303617777
0.7815461363
0.9997531139
-3.6142422015
6.1277671588
0.9997531139
0.5509112667
3.2105733415
0.9997531139
-2.9146066165
5.1406556021
0.9997531139
-1.0555432245
3.3321797964
0.9997531139
-0.6238840087
2.1684287777
0.9997531139
1.4698389961
1.9532892075
0.9997531139
-0.7018288927
3.2918903881
0.9997531139
-0.2246040449
1.8176584953
0.9997531139
-3.6382179483
4.0238536627
0.9997531139
-0.8070941659
8.9132953999
0.9997531139

Table 4-18B: This table shows the expression of the genes listed by Cahoy as enriched in
astrocytes in vivo. Data is shown for the rat/mouse comparison of astrocytes, corrected for
species averages. A positive logFC value indicates the gene was found to be more expressed in
rats, and negative in mice.
It can be clearly seen from tables 4-17 and 4-18 that the expression values of previously
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published genes which were enriched in one setting or the other do not follow their previously
reported expression in this experiment- many of what were the most significantly different genes
in the Cahoy paper are not significantly different here, or may even be significantly different in
the opposite direction. There are a number of possible explanations for this discrepancy: firstly,
the Cahoy experiment used microarrays, while these reported data are from RNAseq. Any bias
present in either experiment may have skewed the results found in these genes in either direction,
and it has certainly been previously shown that microarray and RNAseq analysis of the same
samples can result in very different results [Liu et al., 2011]. Furthermore, the Cahoy in vitro
astrocytes were in fact astrocytes which were freshly harvested from the mouse brain, and then
cultured for five days before sequencing. The astrocytes used in this experiment were ordered,
frozen and pre-isolated, from a supplier, and then were thawed and cultured for ten days before
sequencing was performed. The difference in physical treatment of the cells may well be

Figure 4-27: Difference in expression of morphine addiction-related genes between in vitro rat
and in vivo mouse neurons, corrected for species averages.
responsible for this marked difference in expression.
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K) In vitro/ in vivo comparison: Pathway analysis of differences between settings in neural
tissue: Neurons
Neurons were analyzed in a similar manner to the astrocytes mentioned above. However,
unique among the three cell types analyzed, a prior transcriptomic analysis comparing these cells
in vitro/in vivo was not found in the literature- for this reason the results and discussion are more
limited. Pathway analysis was conducted with GAGE and SPIA, the significant results of which
are shown in table 4-19 and 4-20 respectively. The pathway maps for morphine addiction are
then shown in figure 4-27. Additional pathway maps are shown in Appendix A.
Pathway
mmu04740 Olfactory transduction
mmu04080 Neuroactive ligand-receptor interaction
mmu04540 Gap junction
mmu01040 Biosynthesis of unsaturated fatty acids
mmu04971 Gastric acid secretion
mmu04950 Maturity onset diabetes of the young
mmu04020 Calcium signaling pathway
mmu04914 Progesterone-mediated oocyte maturation
mmu04514 Cell adhesion molecules (CAMs)
mmu04940 Type I diabetes mellitus
mmu04912 GnRH signaling pathway
mmu05340 Primary immunodeficiency
mmu05310 Asthma
mmu00604 Glycosphingolipid biosynthesis - ganglio series
mmu04916 Melanogenesis
mmu04730 Long-term depression
mmu00534 Glycosaminoglycan biosynthesis - heparan sulfate
mmu05330 Allograft rejection
mmu04960 Aldosterone-regulated sodium reabsorption
mmu04140 Regulation of autophagy
mmu04722 Neurotrophin signaling pathway
mmu05320 Autoimmune thyroid disease
mmu04720 Long-term potentiation
mmu04260 Cardiac muscle contraction
mmu04742 Taste transduction
mmu04973 Carbohydrate digestion and absorption
mmu04966 Collecting duct acid secretion
mmu04145 Phagosome
mmu04970 Salivary secretion
mmu04062 Chemokine signaling pathway
mmu05150 Staphylococcus aureus infection
mmu00564 Glycerophospholipid metabolism
mmu04340 Hedgehog signaling pathway
mmu05012 Parkinson's disease
mmu04664 Fc epsilon RI signaling pathway
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p.value
8.45751834736977E-005
0.0105825511
0.0253766345
0.0474577624
0.0618313762
0.1017910168
0.1074571664
0.107891391
0.1264973921
0.1273116821
0.1296689416
0.1371473616
0.1842385058
0.1869630299
0.1873834677
0.1927054145
0.1954235382
0.2011771601
0.2191424479
0.2267125497
0.2273195087
0.2277358555
0.2293782643
0.2330715942
0.2489005027
0.2495397652
0.2514447946
0.2539999516
0.2630768613
0.2734150862
0.3132503477
0.3339597712
0.3517586614
0.3637449946
0.3650984702

mmu03320 PPAR signaling pathway
mmu04622 RIG-I-like receptor signaling pathway
mmu05416 Viral myocarditis
mmu04614 Renin-angiotensin system
mmu00982 Drug metabolism - cytochrome P450
mmu04930 Type II diabetes mellitus
mmu03015 mRNA surveillance pathway
mmu00350 Tyrosine metabolism
mmu00601 Glycosphingolipid biosynthesis - lacto and neolacto series
mmu05217 Basal cell carcinoma
mmu00500 Starch and sucrose metabolism
mmu04360 Axon guidance
mmu05160 Hepatitis C
mmu05020 Prion diseases
mmu04270 Vascular smooth muscle contraction
mmu04976 Bile secretion
mmu00270 Cysteine and methionine metabolism
mmu00650 Butanoate metabolism
mmu04010 MAPK signaling pathway
mmu02010 ABC transporters
mmu04070 Phosphatidylinositol signaling system
mmu00561 Glycerolipid metabolism
mmu04630 Jak-STAT signaling pathway
mmu04672 Intestinal immune network for IgA production

0.3685758782
0.3708679366
0.3766625065
0.3820733085
0.3883338081
0.3900023248
0.3903585739
0.4042105443
0.4081708598
0.4087053451
0.4131783596
0.4247743231
0.4440689339
0.4464479395
0.4480189992
0.4562073549
0.4582749273
0.458696163
0.4631324046
0.4681975035
0.473296118
0.4768888382
0.4836118558
0.4953559177

Table 4-19: GAGE pathway enrichment results between in vitro rat and in vivo mouse neurons,
corrected for species averages. This table shows the names of all pathways significantly enriched
between the two samples to a significance level of p<0.05.
Name
Malaria
HTLV-I infection
Salivary secretion
Chagas disease (American trypanosomiasis)
Morphine addiction
Amphetamine addiction
Hippo signaling pathway
Cell cycle
Estrogen signaling pathway
Gap junction
Dilated cardiomyopathy
Bacterial invasion of epithelial cells
Circadian rhythm
Neurotrophin signaling pathway
Transcriptional misregulation in cancer
Arrhythmogenic right ventricular cardiomyopathy (ARVC)

ID

p-value
5144
5166
4970
5142
5032
5031
4390
4110
4915
4540
5414
5100
4710
4722
5202
5412

0.0125531598
0.0196970232
0.0213113198
0.0216439341
0.0228036698
0.0421627606
0.0550885883
0.0564334168
0.0566115914
0.0650902636
0.0699569546
0.0736472154
0.0763362519
0.0779469158
0.084426284
0.099250952

Table 4-20: SPIA pathway enrichment results between rats and mice in neurons. This table
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shows the names of all pathways significantly enriched between the two samples to a
significance level of p<0.05.
L) In vitro/ in vivo comparison: Pathway analysis of differences between settings in neural
tissue: OPCs
The third and final cell type to be compared in vitro/in vivo is oligodendrocyte progenitor
cells. Unlike the previous two, there are no human OPC samples in this experiment. GAGE and
SPIA pathway data are shown in table 4-21 and table 4-22. Following these, pathway maps for
the cell cycle (figure 4-28) will be shown.
Pathway
mmu03040 Spliceosome
mmu04110 Cell cycle
mmu04972 Pancreatic secretion
mmu00190 Oxidative phosphorylation
mmu04120 Ubiquitin mediated proteolysis
mmu05223 Non-small cell lung cancer
mmu00600 Sphingolipid metabolism
mmu04664 Fc epsilon RI signaling pathway
mmu03022 Basal transcription factors
mmu00565 Ether lipid metabolism
mmu00020 Citrate cycle (TCA cycle)
mmu04910 Insulin signaling pathway
mmu04370 VEGF signaling pathway
mmu00240 Pyrimidine metabolism
mmu00230 Purine metabolism
mmu03010 Ribosome
mmu04975 Fat digestion and absorption
mmu03050 Proteasome
mmu03013 RNA transport
mmu05012 Parkinson's disease
mmu05016 Huntington's disease
mmu04330 Notch signaling pathway
mmu00970 Aminoacyl-tRNA biosynthesis
mmu03420 Nucleotide excision repair
mmu05221 Acute myeloid leukemia
mmu04912 GnRH signaling pathway
mmu03018 RNA degradation
mmu00561 Glycerolipid metabolism
mmu00270 Cysteine and methionine metabolism
mmu00250 Alanine, aspartate and glutamate metabolism
mmu04930 Type II diabetes mellitus
mmu04520 Adherens junction
mmu00983 Drug metabolism - other enzymes
mmu04012 ErbB signaling pathway

76

p.value
0.0069969173
0.030783513
0.0334237531
0.0449455488
0.0508828432
0.0555511392
0.0619847292
0.0636661759
0.071396001
0.0867563716
0.0896597453
0.0902532046
0.0932008263
0.1009503806
0.117654293
0.1246385176
0.1278294213
0.1284460954
0.1317833958
0.13431686
0.1359629772
0.1377987023
0.1484080598
0.1577799483
0.170094775
0.1739458596
0.1782004428
0.1879490566
0.1903429263
0.1979631712
0.2109511069
0.2138210919
0.230377301
0.2431704621

mmu04115 p53 signaling pathway
mmu05010 Alzheimer's disease
mmu05212 Pancreatic cancer
mmu00564 Glycerophospholipid metabolism
mmu04977 Vitamin digestion and absorption
mmu04730 Long-term depression
mmu03060 Protein export
mmu05219 Bladder cancer
mmu00603 Glycosphingolipid biosynthesis - globo series
mmu00860 Porphyrin and chlorophyll metabolism
mmu03008 Ribosome biogenesis in eukaryotes
mmu00601 Glycosphingolipid biosynthesis - lacto and neolacto series
mmu03020 RNA polymerase
mmu04966 Collecting duct acid secretion
mmu00620 Pyruvate metabolism
mmu03410 Base excision repair
mmu05213 Endometrial cancer
mmu00640 Propanoate metabolism
mmu05020 Prion diseases
mmu00260 Glycine, serine and threonine metabolism
mmu04950 Maturity onset diabetes of the young
mmu04744 Phototransduction
mmu00330 Arginine and proline metabolism
mmu04130 SNARE interactions in vesicular transport
mmu00562 Inositol phosphate metabolism
mmu05160 Hepatitis C
mmu05100 Bacterial invasion of epithelial cells
mmu04666 Fc gamma R-mediated phagocytosis
mmu04920 Adipocytokine signaling pathway
mmu04140 Regulation of autophagy
mmu04150 mTOR signaling pathway
mmu05214 Glioma
mmu00531 Glycosaminoglycan degradation
mmu04070 Phosphatidylinositol signaling system
mmu04141 Protein processing in endoplasmic reticulum
mmu03015 mRNA surveillance pathway
mmu03320 PPAR signaling pathway
mmu04142 Lysosome

0.2447389068
0.2476143319
0.2581842283
0.258359411
0.2602477093
0.2605485864
0.2674201559
0.2754306691
0.2891691931
0.2921937199
0.29513903
0.2957582419
0.2978167494
0.306586332
0.3076902979
0.3190576096
0.3223006683
0.3323807279
0.3623597571
0.3686296118
0.3691779099
0.374319414
0.3771138659
0.3785173545
0.3844967932
0.3922439935
0.3939398431
0.3948987495
0.3985031407
0.4255714763
0.4423476351
0.4665861318
0.4715434831
0.4786232924
0.4793169877
0.4951944503
0.4955288811
0.499192659

Table 4-21: GAGE pathway enrichment results between rats and mice in OPCs, corrected for
species averages. This table shows the names of all pathways significantly enriched between the
two samples to a significance level of p<0.05.
Name
Systemic lupus erythematosus
Malaria
ECM-receptor interaction
Proteoglycans in cancer
PI3K-Akt signaling pathway
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
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ID

p-value
5322
4.30718881226101E-005
5144
0.0005192691
4512
0.0013445283
5205
0.0106412399
4151
0.0152221238
5412
0.0182329949

Focal adhesion
Cell cycle
Pancreatic cancer
Glutamatergic synapse
Viral myocarditis

4510
4110
5212
4724
5416

0.0226656859
0.0288560759
0.035123647
0.0354632617
0.0499980622

Table 4-22: SPIA pathway enrichment results between rats and mice in OPCs, corrected for
species averages. This table shows the names of all pathways significantly enriched between the
two samples to a significance level of p<0.05.
Figure 4-28:
Difference in
expression of cell
cycle-related
pathways between
rat and mouse
OPCs correcting for
species averages.
Red indicates genes
more expressed in
rats, blue in mice.

A previously published paper [Dugas et al., 2006] made a comparison of in vitro and in vivo
OPCs using microarrays, and concluded that for many aspects of the expression profile of the
cell- in particular myelin-related genes- were very similar in terms of expression to OPCs in vivo.
In fact, previous data suggests that OPCs should generally be nearly identical in vitro to in vivo
counterparts [Baumann et al, 2001]. However, this appears to not be the case for the cells
presented here- for example, the myelin-related genes mentioned in the Dugas paper were
examined in this comparison and are shown in table 4-23. As can be seen, of the seven relevant
genes to make it into the cross-species annotation, only three were not shown to be significantly
differentially expressed- but this changes drastically in table 4-23B, where after correcting for
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species averages, only one gene remains significantly differently expressed. This illustrates the
importance of correcting for species averages, as bias introduced in this manner has a huge effect
on whether or not the data resembles previously published data for the cell types in question.
Gene
logFC
ENSMUSG00000037625.6
ENSMUSG00000032854.8
ENSMUSG00000027858.8
ENSMUSG00000076439.7
ENSMUSG00000032517.10
ENSMUSG00000027375.9
ENSMUSG00000031775.4

logCPM
-9.0194770279
10.2755037954
4.9205982829
-5.4227081358
-1.5728853564
-1.4092930124
-0.369962467

FDR-adjusted p-value
7.6870443647
1.8637838069412E-054
6.9784753023
1.23270503409118E-033
1.5056869746
4.87760700042238E-010
0.9174398965
4.79218827354167E-008
0.5586784917
0.1391799949
0.893084531
0.2107252262
0.0672180854
0.725939383

Table 4-23A: Expression information regarding the myelin-related genes examined by Dugas. A
positive logFC indicates increased expression in OPCs in rats, a negative value in mice.
Gene
logFC
ENSMUSG00000032854.8
ENSMUSG00000032517.10
ENSMUSG00000027858.8
ENSMUSG00000031775.4
ENSMUSG00000027375.9
ENSMUSG00000076439.7
ENSMUSG00000037625.6

logCPM
4.5486593295
-1.7882821962
1.2225656308
1.1474207249
0.9115189278
-0.6048902674
0.17318373

FDR-adjusted p-value
6.9784753023
4.34329959234785E-014
0.5586784917
0.2257689803
1.5056869746
0.2368827654
0.0672180854
0.4456698265
0.893084531
0.8542662111
0.9174398965
0.9998174978
7.6870443647
0.9998174978

Table 4-23B: Expression information regarding the myelin-related genes examined by Dugas,
corrected for differences between species. A positive logFC indicates increased expression in
OPCs in rats, a negative value in mice.
M) In vitro/ in vivo comparison: Summary
After in vitro/in vivo comparisons of all three cell types examined, numerous pathways
were found to be significantly differently expressed between the two. After consultation with
previously published work, the astrocyte expression was found to follow reasonably well the
models previously made describing astrocyte gene expression in vitro, with a couple of
exceptions. The numerous differences between cell types indicates that care should be taken
when selecting in vitro cells to use in place of in vivo cells for the same purpose, and neural cells
absolutely behave significantly differently in vitro than they do in the brain itself. However,
confounding effects present in this analysis should also be accounted for, which are discussed in
the discussion section.
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Section 5
Discussion and future work: Implications of different expression of neural cell types in vitro
compared to the same cell types in vivo using the developed protocol.
Gene expression and pathway among cell types in rats have shown that the rat cells raised
in vitro for this experiment indeed exhibit fairly usual and canonical expression pathways in the
cell types in question, indicating that they are likely to indeed be good representative models of
in vitro cells of their own cell types. Lists of genes and pathways demonstrated to be
significantly different in pairwise comparisons of the samples constitute the first publication of
comparisons of transcription between these cell types in rats.
Similar analyses conducted on the same samples using the cross-species annotation
indicate that the cross-species annotation generated for rats reflects the true expression within the
cells examined quite well, and therefore is fit to be compared to other samples using the same
annotation. When the human in vitro samples were analyzed in a similar way, it was found that
the cross-species annotation did not reflect the true expression within the samples nearly as well
as was the case with rats. As the generation of the cross-species annotation is a pair-wise genome
alignment based on orthology, it will become worse as evolutionary distance from the base
species to the target species increases- this shows that while rats are suitably closely related to
mice for the cross-species comparison to work well, the human is not so robust, something which
should be considered when performing cross-species comparisons in the future.
Comparisons were then presented quantifying differences in expression of these cell
types in vivo against the rat and human in vitro data. Due to the finding that the human data did
not translate as well across species, each of these comparisons were made using, in turn, all in
vitro data, and only the rat subset of the in vitro data. This enables the presentation of as much
data as possible while still presenting data which remains valid despite the possibility that the
human data is not useful for this purpose. It has previously been established that humans and
mice neural tissue presents significantly different transcriptomic profiles among orthologous
genes.
Unfortunately, one of the major limitations of this method is its inability to control for
evolutionary differences across species in cell types which are not shared with other cell types
within that species. This means that when reporting results regarding which genes are different
80

between in vitro rat cells and in vivo mouse cells, those differences could be due to the difference
in cell setting, or due to differences introduced by evolutionary divergence. Factors which affect
all of the cells examined in similar ways, such as bias introduced by the cross-species annotation,
can be controlled for by correcting gene expression by the species average. However, if any
genes are different between species in only one cell type, it cannot be reliably controlled for
without the inclusion of, for example, in vitro mouse samples of that cell type, or in vivo rat
samples. Future work may include these to robustly determine the differences in vitro and in vivo
in these cell types using the data already generated.
It can be seen from tables 4-13 and 4-14 that the inclusion of the human data has a
definite skewing effect on the results of the differential expression analyses. The human dataset
does not include any samples of OPC cells- which leaves OPC comparisons free from any effect
that the human data may have. This is illustrated well in figure 4-23, where when comparing
DEG lists of genes upregulated in vitro, there are over two thousand DEGs upregulated in OPCs
in vitro that are not significantly different in astrocytes or neurons. This effect is likely due to the
human data having a “fuzzing” effect on the rat data- as can be seen in figure 4-22B, the
dendrogram actually places the mouse and rat data closer together in terms of similarity of
expression than to the human data. In terms of differential expression analysis, combining these
dissimilar samples will reduce the CPM values for all genes with different expression between
these samples. This makes it more difficult for genes to show up as upregulated in vitro when
human data is included- though as can be seen from figure 4-23, this fuzzing effect does not
affect the number of upregulated genes in mice. Figure 4-24 can be difficult to understand and
interpret. Since each comparison listed with DEGs is actually the result of the comparison of the
results of two different other comparisons- one in vitro, the other in vivo, one cannot look at a
number and state definitively that it is upregulated in one particular cell type. Rather, a positive
logFC value indicates that the gene in question is upregulated either in the first cell type of the
first comparison, or the second cell type of the second comparison- the only way to tell which is
to examine the expression CPM values in the constituent comparisons. The reason for these
comparisons is to cause a deliberate, controlled version of the “fuzzing” described above to test
whether the shift from an in vitro to in vivo setting affects all of the cell types examined in the
same way. If in vitro astrocytes were different from in vivo astrocytes in the same way that in
vitro neurons were different from in vivo neurons, then these comparisons will test this by
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essentially combining the expression values of the in vitro astrocytes with those of the in vivo
neurons, and comparing this against the combined expression values of the in vitro neurons and
in vivo astrocytes. This controls both for differences across settings and across cell types, so if
the setting difference between the two cell types was the same, then one would expect to see
close to zero DEGs as a result. As is shown in table 4-14, while the numbers of DEGs are much
lower than those shown in table 4-13, there are still thousands of DEGs between the
comparisons, from which it may be concluded that a change in setting will have variable effects
on different cell types.
Comparisons of in vitro astrocytes against in vivo astrocytes showed that many pathways
previously shown to be different between cells raised in the two different settings, and the Notch
pathway in particular was shown to have different expression between settings in a way mostly
consistent with previous results. Other pathways shown to be differently expressed include a
large number of pathways involved in the cell's interaction with its extracellular surroundings, as
well as pathways involved in diseases such as Alzheimer's disease. Differences in many of these
same pathways were also shown to be present in neurons, as well as other pathways indicating
significant changes in metabolism, morphology, and intercellular connectivity.
Data presented for oligodendrocyte progenitor cells agrees less robustly with previously
published examinations of in vitro OPCs against in vivo, which found little to no difference in
cell expression regardless of setting. To the contrary, this experiment shows setting-dependent
expression difference in OPCs in the thousands of DEGs, though the number of DEGs is indeed
much lower than either of the other two cell types examined. In table 4-23, it can be seen that
especially after correcting for species averages, myelin-related genes are indeed
Future work may involve the sequencing of mouse cells raised in vitro, which would
provide data to verify the results of the comparisons shown above compared across speciesthese samples would allow for additional robustness in the in vitro/in vivo comparison as well as
providing an opportunity for the quantification of the quality of the cross-species comparison
performed. Additionally, further downstream analysis may be applied to the existing body of data
to subset it further and derive more meaning from the comparisons already made.

82

Section 6
References
Anders, S., McCarthy, D., Chen, Y., Okoniewski, M., Smyth, G., Huber, W., & Robinson, M.
(2013). Count-based differential expression analysis of RNA sequencing data using R and
Bioconductor. Nature Protocols, 8(9), 1765–1786. doi:10.1038/nprot.2013.099
Baumann, N., & Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the
mammalian central nervous system. Physiological Reviews, 81(2), 871–927.
Cahoy, J., Emery, B., & Barres, B. a. (2008). A transcriptome database for astrocytes, neurons,
and oligodendrocytes: a new resource for understanding brain development and function.
The Journal of …, 1–58. Retrieved from http://www.jneurosci.org/content/28/1/264.short
Chiaromonte, F., Yap, V. B., & Miller, W. (2002). Scoring pairwise genomic sequence
alignments. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing,
115–126.
Clarke, L. E., Young, K. M., Hamilton, N. B., Li, H., Richardson, W. D., & Attwell, D. (2012).
Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex,
and piriform cortex of the mouse. The Journal of Neuroscience : The Official Journal of the
Society for Neuroscience, 32(24), 8173–85. doi:10.1523/JNEUROSCI.0928-12.2012
Dugas, J. C., Tai, Y. C., Speed, T. P., Ngai, J., & Barres, B. a. (2006). Functional genomic
analysis of oligodendrocyte differentiation. The Journal of Neuroscience : The Official
Journal of the Society for Neuroscience, 26(43), 10967–10983.
doi:10.1523/JNEUROSCI.2572-06.2006
French, L., Tan, P. P. C., & Pavlidis, P. (2011). Large-Scale Analysis of Gene Expression and
Connectivity in the Rodent Brain: Insights through Data Integration. Frontiers in
Neuroinformatics, 5(July), 12. doi:10.3389/fninf.2011.00012
Gentleman, R. C., Gentleman, R. C., Carey, V. J., Carey, V. J., Bates, D. M., Bates, D. M., …
Zhang, J. (2004). Bioconductor: open software development for computational biology and
bioinformatics. Genome Biology, 5(10), R80. doi:10.1186/gb-2004-5-10-r80
Grewal, S. S., York, R. D., & Stork, P. J. S. (1999). Extracellular-signal-regulated kinase
signalling in neurons. Current Opinion in Neurobiology, 9(5), 544–553. doi:10.1016/S09594388(99)00010-0
Harrow, J., Denoeud, F., Frankish, A., Reymond, A., Chen, C.-K., Chrast, J., … Guigo, R.
(2006). GENCODE: producing a reference annotation for ENCODE. Genome Biology, 7
Suppl 1(Suppl 1), S4.1–9. doi:10.1186/gb-2006-7-s1-s4
Johnson, M. B., Kawasawa, Y. I., Mason, C. E., Krsnik, Z., Coppola, G., Bogdanović, D., …
Sestan, N. (2009). Functional and evolutionary insights into human brain development
through global transcriptome analysis. Neuron, 62(4), 494–509.
doi:10.1016/j.neuron.2009.03.027
Kanehisa, M., & Goto, S. (2000). Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids
Research, 28(1), 27–30. doi:10.1093/nar/28.1.27
Katz, Y., Wang, E. T., Airoldi, E. M., & Burge, C. B. (2010). Analysis and design of RNA
83

sequencing experiments for identifying isoform regulation. Nature Methods, 7(12), 1009–
1015. doi:10.1038/nmeth.1528
Kent, W. J., Baertsch, R., Hinrichs, A., Miller, W., & Haussler, D. (2003). Evolution’s cauldron:
duplication, deletion, and rearrangement in the mouse and human genomes. Proceedings of
the National Academy of Sciences of the United States of America, 100(20), 11484–11489.
doi:10.1073/pnas.1932072100
Kettenmann, H., & Ransom, B. (2013). Neuroglia, 3rd edition (3rd ed.). Oxford University
Press.
Ko, Y., Ament, S. a, Eddy, J. a, Caballero, J., Earls, J. C., Hood, L., & Price, N. D. (2013). Cell
type-specific genes show striking and distinct patterns of spatial expression in the mouse
brain. Proceedings of the National Academy of Sciences of the United States of America,
110(8), 3095–100. doi:10.1073/pnas.1222897110
Kriegstein, A., & Alvarez-Buylla, A. (2009). The glial nature of embryonic and adult neural stem
cells. Annual Review of Neuroscience, 149–184.
doi:10.1146/annurev.neuro.051508.135600.The
Kristiansson, E., Österlund, T., Gunnarsson, L., Arne, G., Larsson, D. G. J., & Nerman, O.
(2013). A novel method for cross-species gene expression analysis. BMC Bioinformatics,
14(1), 70. doi:10.1186/1471-2105-14-70
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., … Durbin, R. (2009). The
Sequence Alignment/Map format and SAMtools. Bioinformatics, 25(16), 2078–2079.
doi:10.1093/bioinformatics/btp352
Liao, Y., Smyth, G. K., & Shi, W. (2013). The Subread aligner: Fast, accurate and scalable read
mapping by seed-and-vote. Nucleic Acids Research, 41(10), 1–17. doi:10.1093/nar/gkt214
Liu, S., Lin, L., Jiang, P., Wang, D., & Xing, Y. (2011). A comparison of RNA-Seq and highdensity exon array for detecting differential gene expression between closely related species.
Nucleic Acids Research, 39(2), 578–588. doi:10.1093/nar/gkq817
Lovatt, D., Sonnewald, U., Waagepetersen, H. S., Schousboe, A., He, W., Lin, J. H.-C., …
Nedergaard, M. (2007). The transcriptome and metabolic gene signature of protoplasmic
astrocytes in the adult murine cortex. The Journal of Neuroscience : The Official Journal of
the Society for Neuroscience, 27(45), 12255–66. doi:10.1523/JNEUROSCI.3404-07.2007
Luo, W., & Brouwer, C. (2013). Pathview: An R/Bioconductor package for pathway-based data
integration and visualization. Bioinformatics, 29(14), 1830–1831.
doi:10.1093/bioinformatics/btt285
Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009). GAGE:
generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics, 10,
161. doi:10.1186/1471-2105-10-161
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012). Differential expression analysis of multifactor
RNA-Seq experiments with respect to biological variation. Nucleic Acids Research, 40(10),
4288–4297. doi:10.1093/nar/gks042
Miller, J. a, Horvath, S., & Geschwind, D. H. (2010). Divergence of human and mouse brain
transcriptome highlights Alzheimer disease pathways. Proceedings of the National Academy
84

of Sciences of the United States of America, 107(28), 12698–703.
doi:10.1073/pnas.0914257107
Milner, R., & Campbell, I. L. (2002). The integrin family of cell adhesion molecules has multiple
functions within the CNS. Journal of Neuroscience Research, 69(3), 286–291.
doi:10.1002/jnr.10321
Mortazavi, A., Williams, B. a, McCue, K., Schaeffer, L., & Wold, B. (2008). Mapping and
quantifying mammalian transcriptomes by RNA-Seq. Nature Methods, 5(7), 621–628.
doi:10.1038/nmeth.1226
Nam, D., & Kim, S. Y. (2008). Gene-set approach for expression pattern analysis. Briefings in
Bioinformatics, 9(3), 189–197. doi:10.1093/bib/bbn001
Oshlack, A., Robinson, M. D., & Young, M. D. (2010). From RNA-seq reads to differential
expression results. Genome Biology, 11(12), 220. doi:10.1186/gb-2010-11-12-220
Pinto, L., Mader, M. T., Irmler, M., Gentilini, M., Santoni, F., Drechsel, D., … Götz, M. (2008).
Prospective isolation of functionally distinct radial glial subtypes--lineage and transcriptome
analysis. Molecular and Cellular Neurosciences, 38(1), 15–42.
doi:10.1016/j.mcn.2008.01.012
Richardson, W. D., Young, K. M., Tripathi, R. B., & McKenzie, I. (2011). NG2-glia as
multipotent neural stem cells: fact or fantasy? Neuron, 70(4), 661–73.
doi:10.1016/j.neuron.2011.05.013
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2009). edgeR: A Bioconductor package for
differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 139–
140. doi:10.1093/bioinformatics/btp616
Robinson, M. D., & Smyth, G. K. (2008). Small-sample estimation of negative binomial
dispersion, with applications to SAGE data. Biostatistics, 9(2), 321–332.
doi:10.1093/biostatistics/kxm030
Rowitch, D. H., & Kriegstein, A. R. (2010). Developmental genetics of vertebrate glial-cell
specification. Nature, 468(7321), 214–22. doi:10.1038/nature09611
Rumble, S. M., Lacroute, P., Dalca, A. V., Fiume, M., Sidow, A., & Brudno, M. (2009).
SHRiMP: Accurate mapping of short color-space reads. PLoS Computational Biology, 5(5),
1–11. doi:10.1371/journal.pcbi.1000386
Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995). Quantitative monitoring of gene
expression patterns with a complementary DNA microarray. Science (New York, N.Y.),
270(5235), 467–470. doi:10.1126/science.270.5235.467
Schwartz, S., Kent, W. J., Smit, A., Zhang, Z., Baertsch, R., Hardison, R. C., … Miller, W.
(2003). Human – Mouse Alignments with BLASTZ. Genome Research, 13(1), 103–107.
doi:10.1101/gr.809403.
Sim, F., McClain, C., & Schanz, S. (2011). CD140a identifies a population of highly
myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte
progenitor cells. Nature …, 29(10), 934–941. doi:10.1038/nbt.1972.CD140a
Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential
expression in microarray experiments. Statistical Applications in Genetics and Molecular
85

Biology, 3(1), Article3. doi:10.2202/1544-6115.1027
Tan, P. P. C., French, L., & Pavlidis, P. (2013). Neuron-Enriched Gene Expression Patterns are
Regionally Anti-Correlated with Oligodendrocyte-Enriched Patterns in the Adult Mouse and
Human Brain. Frontiers in Neuroscience, 7(February), 5. doi:10.3389/fnins.2013.00005
Tang, F., Barbacioru, C., Nordman, E., Li, B., Xu, N., Bashkirov, V. I., … Surani, M. A. (2010).
RNA-Seq analysis to capture the transcriptome landscape of a single cell. Nature Protocols,
5(3), 516–535. doi:10.1038/nprot.2009.236
Tarca, A. L., Draghici, S., Khatri, P., Hassan, S. S., Mittal, P., Kim, J.-S. S., … Romero, R.
(2008). A novel signaling pathway impact analysis. Bioinformatics (Oxford, England),
25(1), 75–82. doi:10.1093/bioinformatics/btn577
Trapnell, C., Williams, B. a, Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., … Pachter,
L. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated
transcripts and isoform switching during cell differentiation. Nature Biotechnology, 28(5),
511–515. doi:10.1038/nbt.1621
Wilhelm, B. T., Marguerat, S., Goodhead, I., & Bähler, J. (2010). Defining transcribed regions
using RNA-seq. Nature Protocols, 5(2), 255–266. doi:10.1038/nprot.2009.229
Zhang, Y., Chen, K., Sloan, S. a, Bennett, M. L., Scholze, A. R., Keeffe, S. O., … Wu, X. J. Q.
(2014). An RNA-Sequencing Transcriptome and Splicing Database of Glia , Neurons , and
Vascular Cells of the Cerebral Cortex, 34(36), 1–19. doi:10.1523/JNEUROSCI.186014.2014

86

Appendix A

Figure A-1: Difference in expression of the axon guidance pathways between astrocytes and
neurons in rat cells in vitro. Red indicates genes more expressed in astrocytes, blue in neurons.

Figure A-2: Difference in expression of the focal adhesion pathway between astrocytes and
neurons in rat cells in vitro. Red indicates genes more expressed in astrocytes, blue in neurons.
1

Figure A-3: Difference in expression of the focal adhesion pathway between astrocytes and
OPCs in rat cells in vitro. Red indicates genes more expressed in astrocytes, blue in OPCs.

Figure A-4: Difference in expression of the axon guidance pathways between neurons and OPCs
in rat cells in vitro. Red indicates genes more expressed in neurons, blue in OPCs.
2

Figure A-5: Difference in expression of the axon guidance pathways between astrocytes and
neurons in rat cells in vitro, using the cross-species annotation. Red indicates genes more
expressed in astrocytes, blue in neurons.

Figure A-6: Difference in expression of the focal adhesion pathway between astrocytes and
neurons in rat cells in vitro using the cross-species annotation. Red indicates genes more
expressed in astrocytes, blue in neurons.
3

Figure A-7: Difference in expression of the focal adhesion pathway between astrocytes and
OPCs in rat cells in vitro using the cross-species annotation. Red indicates genes more
expressed in astrocytes, blue in OPCs.

Figure A-8: Difference in expression of the axon guidance pathways between neurons and OPCs
in rat cells in vitro using the cross-species annotation. Red indicates genes more expressed in
neurons, blue in OPCs.
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Figure A-9: This heatmap shows the
expression of the 20 most significant DEGs
in each direction for the pairwise
comparison of astrocytes to neurons in
humans. Data is shown for all samples.

Figure A-10: The 200 genes with the
highest expression in the experiment,
grouped by similarity of expression
across rows. Expression by
individual sample is shown.

5

Figure A-11: Difference in expression of the focal adhesion pathway between in vitro and in
vivo astrocytes. Red indicates genes more expressed in vitro, blue in vivo.

Figure A-12: Difference in expression of the focal adhesion pathway between rat and mouse
astrocytes. Red indicates genes more expressed in rats, blue in mice.
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Figure A-13: Difference in expression of the Alzheimer's disease pathway between in vitro
and in vivo astrocytes. Red indicates genes more expressed in vitro, blue in vivo.

Figure A-14: Difference in expression of the Alzheimer's disease pathway between rat and
mouse astrocytes. Red indicates genes more expressed in rats, blue in mice.
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Figure A-15: Difference in expression of the axon guidance pathways between in vitro and in
vivo settings in neurons. Red indicates genes more expressed in vitro, blue in vivo.

Figure A-16: Difference in expression of the axon guidance pathways between rat and mouse
neurons. Red indicates genes more expressed in rats, blue in mice.
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Figure A-17:
Difference in
expression of the
Alzheimer's
disease
pathways
between in vitro
and in vivo
settings in
neurons. Red
indicates genes
more expressed
in vitro, blue in
vivo.

Figure A-18:
Difference in
expression of the
Alzheimer's
disease
pathways
between rat and
mouse neurons.
Red indicates
genes more
expressed in
rats, blue in
mice.
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Figure A-19:
Difference in
expression of cell
cycle-related
pathways between
rat and mouse
OPCs. Red indicates
genes more
expressed in rats,
blue in mice.
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